TSS:Hg 7913.1

Basic information about the TSS

---

TSS ID: hg_7913.1 Species: human Chr: chr1		Start: 203626852 End: 203626863 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: CR749393 Distance: 0 GeneID: 493 HGNC/MGI_ID: HGNC:817 UniProt_ID: Q68DH9

Gene_name: ATPase plasma membrane Ca2+ transporting 4 Gene_symbol: ATP2B4 Gene_synonyms: PMCA4 Gene_source: HGNC:817

TATA-Box annotation

---

Distance to TSS:	26
Nearest PromoterID:	NM_001684
Entrez ID:	493
Nearest Unigene:	Hs.343522
Nearest Refseq:	NM_001684
Nearest Ensembl:	ENSG00000058668
Gene Name:	ATPase plasma membrane Ca2+ transporting 4
Gene Alias:	ATP2B2|MXRA1|PMCA4|PMCA4b|PMCA4x
Gene Description:	ATPase plasma membrane Ca2+ transporting 4
Gene Type:	protein-coding
CpG%:	0.03
GC%:	0.58209
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ATP2B4 p2@ATP2B4 p3@ATP2B4 p4@ATP2B4 p5@ATP2B4 p6@ATP2B4 p7@ATP2B4 p8@ATP2B4 p9@ATP2B4
Sample		p1@ATP2B4	p2@ATP2B4	p3@ATP2B4	p4@ATP2B4	p5@ATP2B4	p6@ATP2B4	p7@ATP2B4	p8@ATP2B4	p9@ATP2B4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.92	2.34	0.00	0.00	0.00	0.00	0.00	6.43	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1.82	1.42	0.20	0.00	0.00	0.20	0.00	9.10	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2.51	2.70	0.39	0.00	0.00	0.00	0.00	6.94	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.87	1.66	0.21	0.00	0.21	0.00	0.00	4.78	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.47	1.80	0.00	0.00	0.00	0.22	0.22	6.52	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	2.33	0.58	0.00	0.00	0.00	0.00	0.00	6.59	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.96	1.74	0.00	0.00	0.00	0.00	0.00	11.11	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2.18	0.48	0.24	0.00	0.00	0.00	0.00	8.96	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1.71	0.85	0.00	0.00	0.00	0.00	0.00	9.19	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	1.16	0.58	0.00	0.00	0.00	0.00	19.13	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	3.23	2.43	0.40	0.00	0.00	0.00	0.00	13.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.85	0.81	0.00	0.41	0.00	0.00	0.00	17.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.78	15.31	14.18	2.90	2.58	0.97	1.29	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.46	13.98	8.72	3.01	2.26	2.71	2.26	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	46.11	16.69	12.51	3.95	2.85	1.54	0.66	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	34.45	11.07	9.31	3.02	1.76	1.26	1.26	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	42.81	9.83	8.08	3.28	2.84	2.62	0.87	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	48.51	12.23	5.91	1.69	1.69	3.37	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	44.25	8.00	8.53	4.27	1.07	1.60	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	38.21	12.79	9.93	2.26	1.05	1.50	1.50	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	36.62	12.30	8.15	3.34	1.74	1.74	0.94	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	36.94	11.74	12.26	2.76	2.24	3.28	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	39.16	13.31	9.44	3.88	0.90	1.94	0.90	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.97	11.65	7.77	2.43	1.70	1.94	0.73	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.79	9.55	8.26	5.42	1.81	1.29	1.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.15	12.34	9.50	4.11	2.22	2.85	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	54.40	7.14	7.69	4.40	2.20	0.55	1.10	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	45.97	15.56	10.37	4.95	0.24	1.65	1.89	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.77	14.05	8.72	3.72	2.58	0.48	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.36	11.58	9.77	3.08	1.99	1.63	0.54	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.49	9.21	6.70	2.30	1.26	1.88	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.97	8.79	10.16	1.95	1.37	2.54	1.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.94	11.40	7.17	5.91	1.90	1.06	1.90	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	53.44	10.56	7.75	2.31	2.97	1.65	1.32	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.54	9.72	8.79	4.86	1.87	1.50	1.12	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.92	11.11	6.32	2.49	1.72	0.57	0.38	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.54	11.65	6.13	3.68	0.41	1.02	0.82	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.04	9.27	8.06	3.43	1.01	0.60	1.01	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.33	10.26	7.29	5.40	1.35	1.35	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.09	7.20	6.96	1.44	1.92	1.44	1.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	29.88	8.00	7.76	1.65	1.65	1.88	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	41.14	10.83	9.08	2.93	1.17	1.17	0.73	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.63	9.91	9.91	3.37	1.48	1.27	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.45	8.04	8.92	2.27	0.87	1.22	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.14	11.04	10.04	2.01	2.61	1.20	0.80	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	5.82	6.51	2.33	1.16	1.16	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.51	6.72	7.68	2.16	0.72	0.96	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.55	8.05	5.66	4.47	2.09	0.00	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.39	8.14	8.14	3.11	0.72	1.68	0.72	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.67	6.67	7.28	1.01	0.81	1.82	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.52	6.15	7.58	2.66	1.64	1.02	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.02	7.78	8.23	1.56	2.67	2.22	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.87	4.61	9.23	3.55	1.77	1.42	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	27.17	6.30	4.64	0.99	0.33	1.33	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32.72	8.39	5.03	0.84	2.52	2.52	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	30.31	4.59	5.05	1.38	1.84	1.84	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.23	2.59	5.19	0.65	0.97	2.27	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.48	5.78	2.57	1.61	1.28	0.64	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.15	5.03	11.00	3.14	1.57	1.57	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	5.64	1.41	0.71	1.41	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.90	3.93	3.36	0.56	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	2.39	7.17	3.18	0.00	1.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.95	5.10	6.12	1.36	2.72	0.00	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	2.27	3.25	0.97	0.97	1.95	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	2.84	3.19	2.48	0.35	0.71	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	15.79	0.00	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	87.27	17.55	15.11	5.85	3.41	1.46	1.46	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	75.37	15.37	18.84	7.93	2.98	1.98	1.49	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	82.09	22.52	17.36	8.44	2.35	4.22	2.35	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	108.30	13.91	14.90	8.94	2.32	4.97	2.65	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	89.09	14.23	14.85	10.21	1.55	4.02	4.02	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	84.39	13.76	17.12	8.26	4.28	3.06	2.75	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	42.76	7.92	5.70	3.64	0.79	1.11	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	44.76	10.75	20.21	4.97	2.09	1.28	1.76	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	59.54	9.67	15.14	5.98	2.16	2.42	0.64	0.64	0.00
Adipocyte - omental, donor2	11474-119C7	33.64	13.45	6.73	1.49	0.75	2.24	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	55.60	15.07	43.54	3.35	1.34	4.35	0.33	2.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	33.81	6.38	8.93	3.83	0.64	3.19	0.00	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	7.70	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	73.16	10.39	13.10	4.97	2.71	3.61	3.16	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	43.62	13.90	8.86	3.30	0.87	0.87	1.04	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	50.46	13.89	8.41	6.85	0.98	1.17	2.15	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	25.74	6.43	2.06	4.89	0.26	1.03	0.77	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	83.91	11.71	9.48	10.31	0.28	0.56	1.39	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	73.48	12.34	9.99	10.58	0.00	1.76	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	198.91	45.93	122.42	19.87	7.48	12.15	2.73	1.45	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	61.32	11.94	13.88	6.78	0.32	1.29	1.29	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	89.04	20.26	25.59	10.13	0.53	2.13	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	174.72	31.16	27.82	17.81	4.45	6.68	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	191.31	39.93	147.23	15.80	8.32	11.23	3.74	2.91	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	105.74	16.58	31.40	11.80	1.76	2.26	1.51	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	127.30	25.20	47.45	8.51	2.95	5.89	1.31	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	165.33	28.01	77.34	16.14	2.74	7.61	2.74	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	43.76	8.62	12.38	3.76	2.21	1.77	1.55	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	25.82	7.89	7.17	0.72	0.00	1.43	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	2.40	2.40	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	133.67	26.81	19.43	5.58	2.16	3.42	1.80	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	51.88	16.73	13.39	10.04	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	93.68	21.98	17.05	6.78	2.47	2.47	1.85	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	57.56	19.68	19.68	6.87	2.98	4.58	4.12	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	45.06	23.76	18.37	4.16	1.47	5.14	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	70.54	15.73	38.19	8.54	2.25	5.84	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	79.45	14.33	40.81	7.81	2.17	5.21	2.17	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	6.42	17.12	2.14	2.14	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	60.38	18.83	27.50	6.88	1.49	2.69	1.20	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	67.03	15.18	22.76	3.79	3.79	7.59	1.26	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	54.79	9.24	27.06	5.94	5.28	2.64	1.98	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	60.10	12.67	28.91	6.82	2.60	3.25	3.25	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	70.39	16.99	30.58	6.31	3.88	5.34	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	69.48	8.91	29.69	4.16	2.38	1.19	1.78	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	58.38	14.69	26.74	5.65	3.39	3.39	2.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	50.07	15.96	30.48	6.53	4.35	4.35	4.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	45.14	2.51	23.82	5.02	6.27	2.51	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	75.94	11.53	33.11	6.59	5.27	3.29	2.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	60.05	19.11	24.57	5.46	0.00	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	60.62	9.35	28.50	6.33	3.77	3.92	2.41	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	71.26	21.43	31.61	6.97	2.14	5.36	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.24	16.82	35.52	5.67	3.02	3.97	1.13	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	80.72	13.36	26.73	5.61	4.01	3.74	1.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	42.92	7.80	24.39	5.85	2.93	5.85	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	62.86	18.08	36.82	6.47	3.32	3.81	1.99	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	57.63	10.81	28.82	6.00	3.60	3.60	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	77.88	7.08	31.86	7.08	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	69.47	18.53	37.74	5.66	3.95	5.32	3.09	0.86	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	0.00	20.97	4.19	0.00	8.39	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	65.53	9.22	42.23	1.94	1.94	2.43	2.43	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	61.85	16.70	43.64	9.11	2.66	6.07	1.90	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	64.20	8.48	33.92	3.63	6.06	4.85	4.85	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	61.56	15.96	39.90	5.13	3.99	6.84	3.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	72.68	19.67	44.89	7.70	3.85	6.63	2.57	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.91	11.87	26.84	6.71	2.32	2.84	4.13	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	65.22	13.14	30.50	6.57	2.82	4.22	2.35	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	56.59	16.08	27.97	5.14	2.89	4.50	3.22	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	50.66	11.42	22.83	2.85	0.71	2.85	2.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	62.59	15.21	29.25	3.51	1.75	3.51	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	75.87	17.46	28.00	3.01	5.12	2.71	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	53.46	10.69	36.83	2.38	4.75	3.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	54.92	12.21	32.04	4.58	2.03	4.58	1.53	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.67	16.55	31.58	5.35	2.55	3.31	1.78	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	54.64	8.26	25.41	6.35	3.18	0.64	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	56.53	15.10	36.25	6.04	3.02	3.02	1.73	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	62.02	16.30	46.36	5.29	4.02	3.81	1.27	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	54.23	6.09	20.59	7.25	1.74	2.90	2.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	61.41	9.45	31.18	3.78	2.83	3.78	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	64.42	19.50	37.46	5.09	2.37	3.90	1.19	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	48.64	11.58	25.48	9.27	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	63.38	10.56	23.24	4.23	2.11	6.34	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	62.39	16.51	33.66	4.93	3.86	4.93	2.14	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	72.80	6.62	19.85	6.02	3.01	6.02	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.20	11.66	24.79	2.19	2.19	3.64	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	63.22	13.56	34.94	6.21	2.30	5.52	3.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	68.86	17.85	22.95	5.10	10.20	5.10	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	77.29	9.15	42.20	6.10	2.80	5.85	3.81	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	61.31	14.66	32.41	4.95	4.13	4.54	2.06	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	59.36	8.57	24.17	4.90	2.75	2.45	2.14	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	61.19	11.47	34.42	0.48	3.35	3.35	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	57.87	11.53	22.40	4.88	2.88	2.44	1.77	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	12.21	36.62	1.53	6.10	4.58	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	53.17	14.95	27.14	4.43	0.55	3.88	2.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	59.58	14.83	22.51	5.56	3.18	3.97	1.59	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.61	8.36	17.81	5.82	1.09	4.36	1.82	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	24.32	12.04	6.75	0.86	1.23	1.72	0.49	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	14.21	9.76	2.74	1.37	0.68	0.34	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	7.13	5.03	3.99	0.84	0.00	0.00	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	25.80	19.52	13.59	1.39	5.93	2.09	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.05	24.27	15.37	5.66	2.43	4.04	2.10	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	27.74	18.65	13.72	3.88	2.54	2.24	1.64	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1.26	2.98	0.23	0.00	0.00	0.00	0.11	0.23	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.75	2.13	0.00	0.13	0.13	0.00	0.00	0.50	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.91	1.93	0.00	0.34	0.11	0.00	0.00	0.46	0.34
Basophils, donor1	12241-129G9	22.23	8.37	1.05	1.31	1.05	0.00	0.52	0.00	3.92
Basophils, donor2	12242-129H1	68.19	24.53	3.61	3.97	1.44	1.08	2.89	0.36	11.18
Basophils, donor3	12243-129H2	17.64	8.82	1.18	0.88	0.15	0.44	0.15	0.00	2.20
Bronchial Epithelial Cell, donor1	11511-119G8	41.61	9.70	3.02	3.23	0.65	0.86	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	5.03	0.46	0.00	0.46	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	28.69	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.02	0.63	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.40	5.61	0.62	1.46	0.42	0.42	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	18.88	6.22	2.07	0.46	0.00	0.69	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	34.91	15.30	3.06	2.52	1.08	1.08	0.36	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.06	2.99	0.10	0.10	0.10	0.00	0.00	3.81	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.03	2.56	0.00	0.00	0.00	0.00	0.00	15.14	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	30.06	17.27	4.16	1.92	1.60	0.32	0.64	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	41.37	0.00	0.00	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	14.65	9.02	0.56	0.00	1.13	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	15.22	10.95	0.74	0.93	0.00	0.00	0.74	0.00	0.74
CD14+ Monocytes, donor3	11381-118B4	16.25	9.44	1.10	1.10	0.00	0.00	0.22	0.22	3.29
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	9.62	8.21	0.00	0.57	0.00	0.00	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.82	11.75	1.90	1.14	0.38	0.00	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.18	15.45	0.33	0.99	0.66	0.33	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	20.53	5.64	1.73	1.16	0.43	0.14	0.00	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	12.67	4.22	1.21	1.21	0.60	0.00	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	25.11	7.82	0.71	2.84	0.95	0.24	0.24	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.37	1.67	0.17	0.00	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	1.10	0.28	0.00	0.00	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.46	1.74	0.50	0.25	0.00	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.35	1.96	0.00	0.00	0.00	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.67	2.49	0.18	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.70	1.96	0.22	0.22	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	2.34	0.23	0.23	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	1.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.26	3.42	0.45	0.89	0.00	0.00	0.45	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.78	1.80	0.80	0.20	0.20	0.20	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.12	1.04	0.42	1.04	0.00	0.00	0.00	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.32	2.52	0.69	0.46	0.00	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.56	1.13	0.45	0.45	0.00	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.93	2.18	1.75	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.30	3.50	0.00	0.27	0.00	0.27	0.00	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2.97	1.22	0.52	0.52	0.17	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.79	0.84	1.26	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.84	1.29	0.37	0.18	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.76	1.76	0.00	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.92	2.09	0.17	0.17	0.17	0.17	0.00	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1.86	2.97	0.37	0.00	0.00	0.00	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	2.37	1.08	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	0.82	0.41	0.41	0.41	0.41	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.71	0.70	0.23	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.71	0.70	0.23	0.00	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	7.19	8.06	0.44	0.00	0.00	0.00	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.23	6.24	0.23	0.00	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	4.33	5.42	0.43	0.22	0.22	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	18.84	11.99	0.62	1.40	0.16	0.31	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	15.54	7.68	0.35	1.05	0.17	0.35	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	23.19	13.16	0.22	0.67	0.22	0.00	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	7.91	6.89	0.00	0.00	0.00	0.00	0.00	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	7.90	5.27	0.00	0.00	0.00	0.00	0.00	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.79	6.95	0.21	0.21	0.00	0.00	0.00	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	14.23	0.00	0.00	0.00	0.00	0.00	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	5.42	0.68	0.68	0.00	0.00	0.00	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	6.21	0.00	1.04	0.00	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.80	5.33	0.00	0.00	0.00	0.00	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.61	5.90	0.00	0.54	0.54	0.00	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	4.91	0.00	1.40	0.00	0.00	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	7.06	0.00	0.00	0.00	0.00	0.78	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	6.59	1.32	0.00	0.00	0.00	0.00	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	0.82	8.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.08	7.98	0.00	0.73	0.00	0.00	0.00	0.00	2.90
CD19+ B Cells, donor3	11705-123B4	5.05	7.07	0.00	0.00	0.50	0.00	0.00	0.00	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.64	0.81	0.00	0.00	0.00	0.00	0.00	7.27	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.99	1.20	0.00	0.80	0.00	0.00	0.40	3.99	0.40
CD34+ Progenitors, donor1	11545-120B6	27.11	6.02	4.02	2.01	2.01	0.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	23.03	11.24	1.69	1.12	0.56	0.56	1.12	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.56	14.65	4.13	1.13	2.25	3.38	0.38	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.68	16.91	4.74	2.25	2.25	0.90	0.68	0.90	2.25
CD4+ T Cells, donor1	11225-116C1	46.42	15.35	3.57	4.64	0.71	0.36	1.43	0.71	3.57
CD4+ T Cells, donor2	11306-117C1	37.97	26.94	3.67	3.67	0.61	0.00	1.22	0.61	9.19
CD4+ T Cells, donor3	11382-118B5	54.59	21.96	5.49	3.05	0.91	0.91	0.91	1.52	6.40
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	30.63	19.40	2.55	1.02	1.79	1.02	0.51	0.00	15.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.24	15.50	2.47	1.80	1.80	0.22	0.22	0.67	12.58
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.25	18.97	0.86	0.29	0.00	0.57	0.29	0.29	8.62
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	19.44	10.43	0.47	0.95	0.00	0.00	0.47	0.47	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	17.56	11.24	0.00	1.40	0.00	0.00	0.00	0.70	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	13.18	0.00	3.30	0.00	0.00	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	62.14	20.38	12.57	3.47	4.62	1.88	3.47	0.43	20.38
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.70	17.29	7.29	5.42	4.24	2.03	1.53	0.34	11.52
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	44.17	21.60	5.00	4.35	1.29	2.26	2.10	0.32	14.35
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	56.93	20.62	3.59	1.79	0.45	1.79	2.69	1.34	13.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	54.16	14.67	5.24	2.45	1.05	1.05	2.10	1.05	13.98
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	99.44	29.04	12.76	3.96	1.32	3.08	3.96	0.88	18.48
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.48	16.44	5.06	0.42	2.95	0.84	0.42	0.84	8.85
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.71	14.96	3.95	1.87	1.45	1.87	0.42	0.62	9.35
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	27.40	11.69	4.34	1.00	0.33	1.00	0.33	0.00	5.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	27.19	10.33	0.27	1.63	0.27	0.00	0.54	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	19.29	17.15	0.54	1.07	0.00	0.00	0.54	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	14.35	0.00	0.00	0.00	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	55.07	21.14	11.13	4.45	4.45	4.64	2.78	0.56	18.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.99	23.39	10.61	4.98	3.25	2.82	1.30	0.87	18.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	54.64	19.75	12.19	4.62	5.25	1.47	1.47	0.63	27.74
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	72.30	16.68	5.56	3.03	2.53	1.01	2.53	0.51	11.12
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.52	15.16	3.90	4.77	0.87	1.73	2.17	0.43	6.50
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	99.37	32.69	5.67	6.54	3.49	2.18	2.61	2.18	13.95
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	68.29	32.66	2.97	3.46	3.96	0.99	3.46	1.98	8.91
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	72.01	26.77	5.54	1.85	0.00	0.92	2.77	0.92	10.16
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	22.33	8.37	6.98	1.40	0.00	1.40	0.00	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	86.68	30.19	3.05	4.98	0.55	0.83	2.49	0.83	10.52
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	114.11	41.96	8.34	4.42	0.74	2.45	3.93	0.25	16.69
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	117.04	36.96	9.24	3.08	0.00	4.62	1.54	0.00	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	103.14	36.53	4.30	6.09	2.86	0.72	3.94	0.36	8.59
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	87.25	22.16	5.54	5.54	0.00	1.38	6.92	0.00	9.69
CD8+ T Cells, donor1	11226-116C2	74.97	21.28	3.27	8.84	0.98	0.98	3.27	1.64	9.82
CD8+ T Cells, donor2	11307-117C2	79.97	27.78	3.00	12.39	1.13	0.00	4.51	1.13	9.76
CD8+ T Cells, donor3	11383-118B6	46.71	20.96	2.02	3.79	0.25	0.50	2.52	0.50	8.08
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.90	2.52	0.23	0.00	0.00	0.00	0.00	1.38	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.35	2.64	0.00	0.24	0.00	0.00	0.00	0.96	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.46	3.01	0.00	0.00	0.27	0.00	0.00	1.64	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	4.50	0.00	0.30	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.40	4.56	0.00	0.00	0.24	0.00	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.09	4.55	0.00	0.23	0.00	0.00	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.39	3.91	0.00	0.22	0.00	0.00	0.00	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.42	5.26	0.00	0.00	0.00	0.00	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.99	4.46	0.00	0.23	0.00	0.00	0.00	0.94	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	4.23	0.00	0.30	0.00	0.00	0.00	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.52	7.26	0.00	0.29	0.00	0.00	0.00	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.20	5.33	0.00	0.00	0.00	0.00	0.27	0.53	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	4.38	0.44	0.44	0.00	0.00	0.00	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.64	1.37	0.46	0.46	0.00	0.00	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	4.48	0.00	0.75	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.60	5.76	0.36	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.60	3.45	0.00	0.00	0.00	0.00	0.00	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.24	3.77	0.00	0.00	0.00	0.00	0.00	1.18	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.39	4.12	0.00	0.00	0.00	0.00	0.00	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.08	5.23	0.00	0.00	0.00	0.00	0.00	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.53	2.89	0.00	0.32	0.00	0.00	0.00	1.60	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.97	6.88	0.00	0.00	0.00	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	5.52	0.00	0.00	0.00	0.00	0.00	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	3.21	0.80	0.00	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	1.40	0.00	0.00	0.00	0.00	0.00	7.69	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	9.02	0.00	1.00	0.00	0.00	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	89.56	23.76	12.79	23.76	1.83	5.48	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	31.62	14.33	6.42	3.46	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	20.42	6.31	2.63	1.68	0.84	0.95	0.32	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	75.23	13.17	19.41	5.89	1.73	2.43	2.43	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	62.90	9.95	9.60	6.04	1.07	1.42	1.42	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	39.14	8.65	7.85	5.23	1.02	0.80	2.96	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	44.76	11.64	2.69	2.69	0.00	2.69	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	26.29	6.87	2.83	4.04	0.81	0.81	3.24	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	59.79	27.31	14.80	4.02	6.20	3.33	0.92	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	28.22	16.03	6.84	2.57	2.35	1.50	0.00	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	18.76	14.51	5.66	2.12	2.04	0.97	0.27	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	106.74	36.22	16.05	7.79	4.22	2.38	3.67	12.56	0.46
Corneal Epithelial Cells, donor1	11526-119I5	15.15	2.20	0.44	1.10	0.44	0.44	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	23.89	5.69	2.28	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	24.80	6.90	2.81	1.79	0.26	0.77	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.85	10.40	9.25	0.66	1.98	1.32	0.66	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	16.40	10.41	11.35	0.63	1.58	1.89	0.63	0.95	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	10.35	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.61	10.58	9.18	0.97	1.51	0.76	0.54	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	39.97	19.47	5.12	2.73	0.68	0.00	0.00	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.16	20.89	3.26	0.65	0.65	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	37.75	22.26	7.74	0.97	0.97	1.94	0.00	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	38.86	7.34	8.00	2.84	1.00	2.50	0.00	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	12.32	11.74	4.11	1.76	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	58.26	11.03	16.40	2.26	2.83	2.83	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	28.31	9.04	4.33	1.18	1.18	1.57	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.18	11.63	15.71	3.49	1.16	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	39.53	12.00	15.06	3.29	1.88	0.71	0.71	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	29.63	10.87	7.54	1.23	1.58	1.05	0.18	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	68.27	19.73	14.85	5.54	2.66	2.66	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	58.72	19.17	12.47	5.17	2.43	1.52	0.91	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	93.59	26.78	22.27	4.23	3.66	5.07	0.85	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	29.12	12.18	12.18	0.59	0.59	2.97	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	20.31	6.77	4.17	1.56	0.00	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	27.65	13.61	13.75	1.13	1.84	2.27	0.28	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	44.81	12.80	15.20	1.60	0.80	2.00	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	41.41	11.53	8.39	1.05	1.57	3.14	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.43	20.38	10.93	4.60	2.24	2.36	0.12	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.11	14.99	9.13	1.96	1.74	1.30	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.97	16.73	6.23	2.32	1.59	1.10	0.12	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	22.75	7.96	10.24	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	69.15	9.08	16.76	2.79	1.40	2.79	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	34.38	11.15	9.73	2.36	0.94	1.10	0.47	0.16	0.00
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	15.25	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	28.05	4.95	1.65	1.65	0.00	0.00	0.00	1.65	1.65
Eosinophils, donor3	12246-129H5	24.97	7.13	3.57	3.57	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	19.79	4.64	1.71	0.98	0.73	0.24	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	6.24	0.00	2.08	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.89	10.67	7.80	3.69	3.28	1.64	1.23	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	68.87	9.09	53.76	8.98	2.85	7.34	3.28	2.74	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.33	3.25	2.49	1.30	0.11	0.54	0.54	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	66.22	13.95	21.71	7.28	3.15	3.40	1.82	0.85	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	225.31	40.40	283.59	26.61	24.16	32.75	15.56	1.23	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	52.73	12.76	16.56	5.06	1.37	2.64	2.43	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	189.71	55.33	62.18	15.55	3.95	8.70	6.32	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	71.09	15.28	20.60	12.96	4.65	2.66	3.99	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	52.62	11.34	17.69	4.08	1.36	4.08	1.36	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.98	4.55	6.06	1.52	0.00	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	25.08	4.26	5.99	2.84	1.26	0.16	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	107.00	29.40	27.28	5.76	2.12	6.37	2.73	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	28.81	9.52	4.57	3.17	0.76	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	34.41	11.07	7.28	2.43	0.91	0.76	0.30	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.32	10.85	6.43	1.34	0.80	1.07	0.40	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	9.49	4.31	1.73	2.59	1.29	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	7.32	5.86	2.93	0.00	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.07	4.84	1.38	0.92	0.69	0.69	0.69	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	52.92	12.38	16.45	6.95	6.28	6.28	3.90	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	59.63	20.66	7.98	4.93	0.70	1.64	1.17	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	44.34	9.91	4.72	1.89	0.47	0.94	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	30.10	12.33	4.11	2.78	1.09	0.36	0.60	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	49.85	18.88	5.88	3.73	1.24	0.79	0.68	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	74.14	18.67	8.37	5.58	0.87	1.57	1.05	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	81.70	24.53	8.93	3.57	2.76	1.62	0.81	0.81	0.00
Fibroblast - Gingival, donor1	11237-116D4	58.93	17.91	8.75	5.83	2.71	1.87	1.46	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	67.33	19.39	16.51	6.81	1.83	2.36	3.14	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	43.36	17.53	5.80	3.03	1.84	1.45	0.40	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	62.27	25.53	7.73	4.83	1.26	1.06	2.22	0.58	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	10.39	6.23	3.12	2.08	1.04	2.08	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.18	8.81	3.00	5.64	0.53	0.88	1.41	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	62.36	22.92	9.51	6.08	2.49	1.71	2.65	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	70.32	20.01	14.74	7.71	2.16	2.16	2.30	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	81.16	13.76	18.35	7.76	2.12	6.35	2.82	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	83.51	19.30	15.94	8.19	3.07	3.51	3.36	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	108.81	22.36	20.73	9.14	4.64	3.68	2.86	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	92.69	19.64	17.44	10.42	2.74	3.18	2.52	0.55	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	43.43	13.50	4.99	4.26	0.73	1.76	2.20	0.44	0.00
Fibroblast - Lung, donor1	11270-116H1	27.19	13.59	1.36	1.36	2.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	56.70	22.38	22.38	4.48	1.49	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	29.97	15.62	3.38	2.11	1.27	1.27	0.42	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	41.65	9.16	2.50	0.00	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	8.39	1.40	1.40	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.44	1.40	0.28	0.28	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	51.96	17.46	0.81	2.84	0.00	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	3.99	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	50.05	22.69	7.76	4.46	2.33	1.16	0.39	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	49.30	23.06	6.22	5.31	1.67	0.91	1.21	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	93.63	30.60	24.78	9.18	2.75	3.67	2.45	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	77.85	22.13	13.74	4.20	1.91	2.67	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	78.84	21.06	13.50	8.64	0.54	2.97	3.51	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	34.10	11.25	3.36	4.41	0.46	1.16	1.74	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.53	6.08	4.20	2.21	0.66	0.77	0.66	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.16	10.57	3.05	2.03	0.41	0.41	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	8.02	2.00	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.21	15.42	5.14	3.56	0.79	1.98	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	255.60	66.68	42.47	18.85	3.18	7.14	5.75	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	82.41	13.85	10.48	7.10	1.78	1.78	1.95	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	135.79	20.69	23.26	9.85	3.15	3.35	3.15	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	403.75	110.11	78.52	26.17	4.21	11.13	5.11	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	100.61	23.43	16.62	5.83	2.27	3.45	1.94	0.54	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	117.93	37.46	14.43	9.11	2.28	2.28	1.52	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	95.33	16.41	10.34	5.74	0.82	2.79	1.15	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	362.12	104.66	102.26	34.09	14.04	17.04	11.63	1.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	71.03	16.78	17.48	4.92	1.81	2.61	2.01	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	279.87	68.31	46.24	22.37	5.14	4.53	6.04	1.51	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	110.27	17.07	15.91	11.27	3.48	3.15	3.23	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	69.58	19.83	21.03	4.96	4.27	4.62	3.42	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	484.11	119.55	117.25	33.17	3.61	15.44	6.90	1.97	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	170.22	34.83	50.92	11.61	3.62	7.03	3.52	1.28	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	195.00	31.71	42.17	12.15	5.74	8.60	4.72	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	65.24	15.53	7.06	3.45	0.78	1.25	0.47	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	22.16	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	79.31	25.27	5.23	6.10	1.74	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.82	8.32	2.95	3.29	1.56	0.69	0.87	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	54.65	14.83	5.99	3.90	0.78	1.56	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.21	10.22	2.30	0.77	0.51	0.26	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	4.59	8.42	3.83	0.00	2.30	0.00	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	6.38	3.83	0.64	0.00	1.28	1.91	0.00	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.14	12.84	5.13	0.00	1.71	0.57	0.00	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.86	15.72	1.65	0.00	2.21	1.65	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.20	13.24	2.74	0.46	2.74	1.14	0.23	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4.95	8.12	3.96	0.40	0.59	0.99	0.00	1.19	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	2.11	20.88	2.91	0.00	2.38	1.32	0.00	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	7.18	11.09	1.96	0.00	0.98	0.00	0.98	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	0.00	7.08	3.10	0.00	0.44	0.44	0.00	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6.78	14.84	4.24	0.42	1.55	1.13	0.00	0.71	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	13.05	15.39	4.93	0.49	1.97	1.23	0.62	1.11	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.72	15.31	6.45	1.07	1.88	1.61	0.27	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.55	17.22	9.04	0.87	2.85	1.86	0.25	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.29	19.24	10.24	1.11	3.74	1.94	0.14	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.31	19.31	12.40	0.81	4.27	2.85	0.20	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.26	24.64	15.06	2.51	3.42	3.65	0.00	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	27.28	24.29	14.82	1.62	4.11	2.49	0.50	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.10	36.28	24.48	0.22	4.59	3.28	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	17.73	21.27	7.39	1.18	1.77	1.48	0.59	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.46	15.90	6.04	0.95	1.59	0.95	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.76	23.46	10.05	1.34	4.24	2.68	0.22	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.41	22.99	6.65	2.22	2.42	1.01	0.20	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.88	13.91	6.62	1.87	2.37	1.02	0.51	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	31.21	16.85	12.33	1.15	4.52	3.10	0.18	0.98	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.44	13.74	10.30	0.62	4.58	2.71	0.73	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.88	14.69	12.98	0.51	3.42	4.44	0.51	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.79	17.04	6.75	2.10	2.32	1.99	0.89	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.20	15.47	8.57	2.08	3.58	1.91	0.42	0.33	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.69	14.09	10.41	1.43	2.86	2.65	0.41	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.88	21.46	7.84	1.65	1.65	1.03	0.00	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.56	20.87	6.11	1.50	2.08	2.65	0.58	0.46	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.35	20.51	7.00	1.50	3.00	0.67	0.50	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	30.42	18.08	5.95	1.76	2.87	0.66	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.88	19.80	4.30	0.98	2.34	0.98	0.74	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.91	23.02	6.00	1.62	2.27	2.27	0.32	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.02	19.56	7.38	0.96	2.57	0.32	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.95	16.96	5.31	1.80	2.37	1.61	0.47	0.57	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.42	19.93	5.85	1.27	0.95	0.79	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.75	29.80	7.91	3.34	3.34	3.04	0.91	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.69	18.50	5.96	1.88	1.67	1.67	1.36	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.59	17.56	4.61	1.76	1.54	1.10	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.64	21.32	3.93	2.52	2.24	0.84	1.12	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.76	16.48	7.22	2.96	1.85	2.04	0.93	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.55	16.58	4.55	1.60	0.80	1.60	0.00	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	59.52	23.72	9.18	4.28	2.60	2.75	0.92	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.56	11.01	4.40	1.68	0.91	0.78	0.39	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	21.69	3.52	2.44	2.44	1.36	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	36.13	23.41	9.95	3.87	2.40	1.84	1.11	0.37	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	44.08	21.05	7.46	3.95	1.97	2.63	1.10	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	47.60	31.74	7.93	2.98	3.97	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.94	13.59	8.44	1.58	1.58	1.06	0.26	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.70	17.75	4.84	2.82	1.21	1.21	0.81	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.03	31.01	8.13	3.81	6.10	1.78	1.02	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2.99	17.72	4.78	0.20	1.59	1.00	0.00	2.19	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	3.24	8.32	1.54	0.31	1.85	0.46	0.31	1.23	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	3.27	14.73	4.09	0.00	2.25	1.23	0.00	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.51	9.70	3.44	0.31	1.56	1.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3.39	7.63	3.39	0.57	0.57	0.57	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.46	18.91	4.15	0.00	1.38	2.77	0.00	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	12.37	4.95	2.47	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.19	12.38	3.87	0.77	0.77	0.77	0.00	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	11.23	4.81	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	10.43	5.22	0.00	0.00	0.00	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.18	14.65	4.23	0.65	2.28	1.30	0.33	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.30	19.35	2.06	0.41	2.06	0.41	0.00	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	13.33	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.63	16.78	8.39	0.28	0.28	0.00	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	12.42	18.30	5.88	0.33	1.63	3.60	0.00	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	4.19	14.26	5.87	0.00	2.52	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	17.49	20.99	11.77	0.32	2.54	0.95	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.93	15.62	7.47	1.02	3.40	3.06	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	27.15	8.35	0.00	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	14.32	26.34	12.60	0.57	2.29	2.29	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	21.01	12.43	1.18	2.37	4.14	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	13.55	13.55	5.08	1.69	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.74	21.95	16.15	0.83	3.73	2.49	0.41	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.66	19.33	10.36	0.23	1.84	4.14	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	31.61	21.07	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.45	19.99	11.53	0.77	2.31	0.77	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.65	26.73	16.62	0.65	1.96	4.56	0.33	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	20.07	12.04	2.01	1.34	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.43	35.06	15.03	1.54	3.85	3.47	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.78	32.52	16.77	0.34	3.42	3.77	0.34	2.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	37.27	27.33	0.00	7.45	4.97	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.82	33.03	18.87	0.94	3.77	2.36	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.12	36.81	11.47	0.60	3.02	3.62	1.21	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	23.91	14.75	0.00	2.54	3.05	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.94	33.10	13.56	0.80	7.98	4.39	0.00	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.61	43.91	16.28	0.99	2.96	5.92	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	37.77	21.25	2.36	3.54	3.54	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	37.34	16.92	0.58	4.67	2.92	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	23.70	35.11	10.09	0.88	3.95	4.83	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	29.67	13.56	3.39	4.24	7.63	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.85	22.09	17.31	1.79	2.98	3.58	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	18.92	15.04	0.49	2.43	4.85	0.49	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	14.84	7.99	4.57	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	7.48	3.74	0.83	0.83	1.66	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	60.72	20.24	4.50	4.50	1.12	3.37	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.99	14.59	6.34	5.71	0.95	1.90	3.17	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	60.15	15.46	12.53	8.35	2.51	2.09	5.43	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.91	6.15	2.55	0.35	0.81	0.46	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.95	5.23	2.19	0.68	0.34	0.68	0.00	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.96	6.60	1.37	0.46	0.23	0.00	0.23	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.21	3.94	2.51	0.77	0.55	0.00	0.00	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	6.02	6.23	2.15	0.43	1.07	0.86	0.86	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.18	5.17	1.94	0.86	1.94	0.65	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.09	5.11	2.24	0.87	0.50	0.37	0.00	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.09	6.86	1.54	0.69	0.69	0.69	0.17	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.73	3.20	0.64	0.32	1.28	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.57	13.43	6.16	3.92	1.68	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.48	6.49	2.60	0.43	1.30	0.87	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	2.64	7.93	2.64	0.00	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	53.61	17.28	11.64	3.88	2.12	1.76	1.06	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	32.69	7.99	7.27	2.91	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.81	7.69	3.32	1.92	0.87	0.52	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	21.79	8.47	3.63	0.00	1.21	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	53.87	10.77	7.54	0.00	1.08	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	63.81	30.06	12.27	4.91	1.84	2.45	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.98	16.32	4.57	1.31	1.96	0.00	1.31	0.65	8.48
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.47	5.42	0.35	0.87	0.87	0.35	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.46	11.94	4.67	2.06	1.37	0.96	0.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37	0.00	0.00	0.00	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	5.54	0.00	0.00	0.00	0.00	0.00	4.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	2.50	2.50	0.00	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81	0.00	0.00	2.56	0.00	0.00	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	6.50	0.00	1.62	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	6.67	0.00	0.00	0.00	0.00	0.00	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	7.26	0.00	0.00	3.63	0.00	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	10.59	0.00	0.00	0.00	0.00	0.00	7.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	5.54	0.00	0.00	0.00	0.00	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	1.89	0.00	0.00	0.00	0.00	0.00	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	4.64	0.00	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.23	5.17	0.00	0.00	0.00	0.00	0.00	3.88	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	8.05	0.00	0.00	0.00	0.00	0.00	8.05	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	4.07	0.00	0.00	0.00	0.00	0.00	3.26	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.52	2.94	0.00	0.42	0.42	0.00	0.00	5.46	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	2.41	0.00	0.00	0.00	0.00	0.00	4.82	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	1.85	0.00	0.00	0.00	0.00	0.00	6.46	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	3.30	0.00	0.00	0.00	0.00	0.00	3.30	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	0.00	0.00	0.91	0.00	0.00	2.72	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	2.15	0.00	0.00	1.08	0.00	0.00	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	5.74	0.00	0.00	0.00	0.00	0.00	4.46	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	5.47	0.00	0.00	0.00	0.00	0.00	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	5.00	0.00	0.00	0.00	0.00	0.00	7.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	0.00	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2.78	3.70	0.00	0.31	0.00	0.31	0.00	4.32	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	5.27	0.00	0.00	0.00	0.00	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	0.00	0.00	0.00	0.00	0.00	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	4.87	0.00	0.70	0.00	0.00	0.00	3.48	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	4.43	0.00	0.00	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	16.21	0.00	0.00	0.00	0.00	0.00	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	5.23	0.00	0.00	0.00	0.00	0.00	5.23	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	0.00	0.00	0.00	0.00	0.00	9.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	3.20	2.13	0.00	0.00	0.00	0.00	6.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	4.16	0.00	1.39	0.00	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	14.25	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1.84	5.52	0.00	0.00	0.00	0.00	0.00	9.20	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	3.03	0.00	0.00	0.00	0.00	0.00	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	2.11	0.00	0.00	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	42.84	9.14	4.65	4.32	0.98	0.90	0.57	0.24	0.00
Keratinocyte - epidermal, donor2	11349-117G8	11.71	2.93	1.17	1.17	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.60	11.36	3.60	2.93	0.28	0.38	0.28	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	62.32	22.36	7.83	4.09	2.95	2.04	1.02	0.11	0.00
Keratocytes, donor1	11527-119I6	9.97	5.16	1.38	0.69	0.34	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	16.41	7.03	0.00	0.00	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	21.14	9.48	1.58	2.77	0.59	0.59	0.79	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	12.94	1.08	0.00	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	51.44	36.68	21.45	2.42	3.11	4.15	0.35	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	17.05	8.48	2.93	1.61	1.61	1.31	0.20	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.31	9.01	3.08	1.07	0.36	0.83	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.16	4.19	1.40	0.00	0.56	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.16	9.29	1.42	0.31	0.16	0.47	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	5.91	0.54	0.54	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.14	2.84	0.95	1.26	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.13	5.93	1.08	0.54	0.11	0.22	0.00	0.43	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.47	6.16	1.64	0.41	0.00	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	2.53	1.77	0.76	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.54	6.47	1.41	0.84	0.42	0.14	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.84	6.33	2.37	0.79	0.00	0.40	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	7.37	1.74	0.19	0.19	0.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.44	4.81	1.48	0.56	0.56	0.19	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.59	3.14	4.53	0.70	0.35	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.35	2.86	1.91	0.48	0.24	0.48	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.79	4.53	1.37	0.27	0.14	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	5.54	1.85	1.23	0.00	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	2.18	1.25	0.31	0.00	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.72	9.15	1.46	0.73	0.18	0.37	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	7.24	2.63	0.33	0.33	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	3.51	1.17	0.29	0.00	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.45	5.97	1.00	0.50	0.25	0.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.55	6.30	1.94	0.97	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.27	2.96	1.62	0.00	0.81	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.69	6.21	1.82	0.45	0.45	0.76	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	3.63	1.04	0.52	0.52	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	5.86	1.68	1.26	0.21	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	11.28	6.47	2.71	0.60	0.15	0.60	0.60	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	9.63	4.82	0.00	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.28	3.95	1.32	0.38	0.19	0.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.85	6.04	0.95	0.32	0.11	0.21	0.00	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	10.18	2.91	1.45	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.95	4.63	0.99	0.00	0.66	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.18	4.34	1.24	0.62	0.25	0.00	0.12	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.51	8.89	2.22	0.37	0.37	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	2.72	1.24	0.74	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	4.12	0.27	0.41	0.14	0.14	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.08	7.40	1.61	0.96	0.32	1.29	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.52	3.35	1.83	0.61	0.91	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.48	8.40	1.68	0.28	0.14	0.70	0.00	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.80	7.47	2.13	0.36	0.36	0.71	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	1.94	0.48	0.00	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	4.36	1.40	0.00	0.62	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	3.22	1.43	0.36	0.36	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.84	2.94	1.96	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	2.83	0.94	0.47	0.47	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.06	6.56	3.71	0.62	0.87	0.74	0.25	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	2.31	0.51	0.26	0.00	0.00	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	5.37	1.19	0.00	0.90	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	10.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	11.88	0.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	3.81	0.00	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	4.92	0.00	1.41	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	7.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	3.09	0.52	0.00	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	2.38	0.00	0.00	0.00	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	4.07	4.07	0.45	0.00	0.23	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.11	4.65	0.00	0.58	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.05	4.05	0.45	0.45	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	5.83	5.96	0.54	0.41	0.14	0.14	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	7.70	0.51	1.54	0.00	0.00	0.51	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.59	8.47	0.35	0.00	0.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	10.70	6.62	0.00	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.34	10.14	0.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.86	7.94	0.00	0.00	0.00	0.00	0.19	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.82	4.91	0.00	0.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	10.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.29	8.54	0.42	0.21	0.83	0.42	0.00	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4.76	6.73	0.28	0.28	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	9.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.26	6.39	0.00	0.29	0.00	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	5.68	4.78	0.00	0.30	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.19	13.28	1.11	1.11	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	9.19	8.84	0.35	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.01	5.16	0.37	0.00	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	9.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	11.90	0.38	0.77	0.38	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	7.36	0.00	0.00	1.13	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	3.28	7.38	0.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	9.49	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	6.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	4.48	3.73	0.75	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	3.72	7.06	0.37	0.00	0.37	0.00	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	6.46	0.00	0.43	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2.57	7.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.33	8.33	0.00	0.33	0.00	0.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	10.86	0.00	0.60	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.13	5.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.28	7.91	0.34	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	4.83	0.54	0.00	0.00	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	4.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.37	14.82	0.00	0.00	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	11.64	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.21	9.20	0.00	0.00	0.00	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	12.36	0.00	0.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.83	8.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.40	10.36	0.49	0.00	0.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	7.53	0.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	9.05	0.50	1.51	0.50	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.56	8.11	0.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.13	9.35	0.45	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.43	10.95	0.00	1.17	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.92	5.28	0.66	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.26	11.94	0.00	0.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.00	9.19	0.44	0.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	7.83	0.00	0.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.51	11.04	0.00	0.00	0.44	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	7.33	0.00	0.39	0.00	0.00	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.60	7.60	0.51	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.69	8.17	0.48	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.94	10.73	0.40	0.40	0.00	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.11	4.86	0.00	0.00	0.00	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	8.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	8.36	0.76	0.00	0.00	0.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.78	3.10	0.52	0.00	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.86	7.86	0.60	0.00	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.14	10.46	0.95	0.32	0.00	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	7.46	0.53	0.53	0.53	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	6.90	0.00	0.57	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.88	6.69	0.51	0.51	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	4.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	7.38	0.57	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.40	9.98	0.83	1.25	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	7.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.60	7.93	0.42	0.42	0.00	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9.76	11.15	0.00	0.46	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	7.36	0.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	17.11	0.00	0.53	0.00	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	8.08	0.40	0.81	0.00	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	4.59	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	7.11	0.89	0.00	0.00	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.69	11.97	1.14	1.14	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	7.67	0.77	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	6.57	0.00	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.70	12.03	0.89	0.45	0.00	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.52	8.06	0.26	0.52	0.00	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	13.93	0.00	0.66	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	6.24	6.24	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	5.24	6.15	0.46	0.23	0.00	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	8.44	8.07	4.95	0.00	0.92	0.18	0.00	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	8.39	11.93	1.57	0.79	0.66	0.52	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	13.81	5.84	2.66	1.06	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	49.12	11.09	4.60	4.12	1.27	1.58	0.95	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	30.99	7.23	2.92	3.06	0.56	1.25	0.00	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	47.23	12.65	5.48	3.19	1.40	0.90	1.20	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	35.33	9.84	1.45	1.74	1.16	0.87	0.58	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.72	8.73	2.74	0.75	0.50	1.50	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	17.63	8.81	4.75	0.00	0.00	0.00	0.68	0.00	2.71
Mast cell, donor1	11563-120D6	17.63	11.79	0.43	1.30	0.43	0.00	0.11	0.11	2.38
Mast cell, donor2	11565-120D8	14.86	9.21	0.89	2.67	0.00	0.30	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	4.95	7.20	0.90	0.90	0.23	0.00	0.00	0.00	0.68
Mast cell, donor4	11567-120E1	13.47	10.81	0.18	1.24	0.35	0.18	0.35	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	24.62	11.31	0.89	1.55	0.89	0.22	0.89	0.22	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	30.35	2.92	1.75	2.92	1.17	0.00	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	19.27	13.08	0.34	0.69	0.23	0.23	0.46	0.34	1.84
Mast cell, expanded, donor8	11941-126A6	16.07	5.69	0.17	0.84	0.50	0.17	0.33	0.50	1.17
Melanocyte - dark, donor1	11502-119F8	12.93	12.04	3.28	0.60	1.29	0.60	0.10	0.30	0.20
Melanocyte - dark, donor2	11582-120F7	32.53	12.81	4.85	2.08	1.73	1.73	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	15.29	9.13	0.87	1.52	0.29	0.36	0.14	0.07	0.00
Melanocyte - light, donor1	11274-116H5	39.02	8.93	3.29	1.41	0.71	0.24	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	16.38	8.87	0.00	0.00	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	22.55	4.34	1.73	1.73	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	15.31	9.37	1.15	1.25	0.42	0.21	0.10	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	18.29	9.95	2.15	1.34	0.81	0.54	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	12.05	9.11	1.07	0.80	1.34	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	25.43	8.56	3.47	0.87	0.37	0.87	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	7.92	9.24	2.64	0.44	0.88	0.44	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	28.77	8.48	3.50	2.85	1.96	1.30	0.41	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	25.95	10.27	2.28	2.85	1.14	0.86	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.70	4.23	3.72	1.41	0.50	0.91	0.40	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	59.14	9.20	5.26	3.94	0.00	1.31	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	7.85	1.31	2.62	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	8.61	3.59	5.74	0.00	0.00	2.87	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	59.72	15.88	12.28	4.24	2.12	2.75	0.64	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	58.31	18.60	17.09	3.02	1.51	2.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.11	9.23	3.96	1.54	0.66	0.44	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	5.11	4.38	0.73	1.46	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.14	9.00	2.66	2.66	0.61	0.41	0.61	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	57.90	18.70	8.73	2.49	0.97	2.22	2.63	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	35.69	7.81	4.83	1.12	0.37	3.72	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.97	12.89	9.87	6.71	1.45	1.71	1.32	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	71.81	10.39	12.76	2.97	1.78	2.08	1.48	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	4.67	4.67	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	18.57	10.89	5.76	1.28	1.28	0.64	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	45.01	8.86	1.77	4.96	1.06	0.35	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.03	15.95	10.01	1.56	0.94	0.63	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	5.81	1.45	1.45	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	166.53	17.24	334.12	19.62	21.74	31.03	9.55	1.59	0.53
Mesothelial Cells, donor2	12156-128G5	88.58	14.01	189.68	4.50	16.52	19.52	5.51	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	115.55	20.52	129.21	11.49	10.91	13.22	3.90	0.94	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	12.15	4.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	2.96	8.87	2.96	0.74	1.23	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.66	5.30	2.36	0.00	0.59	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.86	6.82	2.17	0.31	0.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.07	5.39	2.07	0.00	0.41	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	6.95	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.76	8.26	1.75	0.50	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.65	6.52	0.00	0.00	0.00	0.93	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.08	7.72	2.85	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.38	5.94	0.79	0.79	0.40	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	7.08	1.77	0.00	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.52	3.04	1.90	0.76	0.76	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	2.63	3.95	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.40	4.88	2.33	0.64	0.64	0.42	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.09	5.07	2.68	0.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.01	5.52	2.01	0.00	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.90	2.85	1.19	0.00	1.19	0.48	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	1.66	1.66	1.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.99	5.99	0.92	0.00	0.00	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	3.37	2.31	0.63	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.87	4.08	1.22	0.61	0.00	0.41	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	2.15	5.15	1.72	0.43	0.64	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.78	3.11	1.56	0.00	0.22	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.75	3.29	1.31	0.00	0.22	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	2.53	0.51	0.00	1.52	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.26	2.45	0.54	0.27	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	3.23	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	3.27	1.09	1.09	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	1.92	0.96	0.00	0.00	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.40	2.80	2.40	0.00	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	3.00	0.50	0.50	0.00	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.07	1.75	0.88	0.44	0.44	0.00	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	5.52	0.00	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	1.28	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.24	1.98	0.50	0.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	0.00	1.39	0.00	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.39	2.05	0.34	0.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.42	1.42	2.13	0.36	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.24	2.24	0.84	0.28	0.28	0.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	1.66	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	0.58	1.75	0.58	0.58	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.92	1.51	0.90	0.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	2.92	0.42	0.00	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	0.92	2.77	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	1.71	1.14	0.57	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.28	2.07	1.24	0.00	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.37	1.55	1.30	0.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.43	0.86	1.72	0.43	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	2.54	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	1.87	1.07	0.00	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	11.08	2.69	1.20	0.30	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.54	2.54	0.57	0.42	0.00	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2.87	2.55	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.87	3.32	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	2.65	0.76	0.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.69	2.27	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3.44	5.41	0.98	0.74	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	5.21	0.00	1.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	6.76	2.06	0.29	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	6.05	2.02	0.86	0.86	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.26	11.54	2.89	2.06	0.41	1.24	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.23	5.06	0.89	1.49	0.30	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.30	3.94	0.33	0.00	0.00	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	1.05	0.00	0.00	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.37	2.77	0.20	0.00	0.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	6.52	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2.63	4.88	0.38	0.00	0.00	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.20	2.66	1.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.24	2.04	0.00	0.23	0.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	4.42	0.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.10	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.00	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	15.46	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	1.26	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	6.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	104.92	21.33	34.25	6.25	3.88	4.09	2.37	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	143.20	35.54	30.83	7.32	5.75	7.84	5.23	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.72	18.02	10.68	3.34	2.00	2.00	4.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.65	10.85	25.04	5.84	2.09	5.43	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	71.49	20.73	19.58	4.75	3.61	3.04	2.66	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	57.45	23.94	19.15	7.98	1.60	7.98	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	6.80	6.12	3.40	0.68	1.36	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	60.64	14.70	9.19	1.84	1.84	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	23.44	5.86	6.70	3.35	1.67	2.93	2.09	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	80.89	18.36	40.91	6.74	3.72	3.25	4.18	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.97	11.35	9.73	2.43	1.08	3.24	2.16	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.32	13.46	15.35	4.41	2.94	1.68	2.52	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	11.13	33.40	0.00	22.27	11.13	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	65.02	15.39	27.80	8.44	1.49	6.45	4.96	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	31.67	7.04	11.10	3.79	2.44	2.17	1.35	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	56.90	14.73	26.52	4.99	3.63	3.40	3.17	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	32.17	7.84	12.41	3.10	0.98	1.31	1.80	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.73	9.48	11.85	3.28	1.82	1.82	0.91	0.91	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	65.77	12.73	28.11	6.90	4.77	7.96	2.12	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	57.03	10.21	40.22	6.00	1.80	2.40	4.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.30	11.81	19.03	3.94	4.92	5.25	2.30	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	54.15	14.31	27.16	5.20	1.79	4.39	4.72	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.40	11.11	7.94	3.00	1.59	1.76	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	31.65	9.14	25.32	6.33	2.81	4.22	3.52	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	68.96	13.33	37.70	11.95	3.22	3.68	7.36	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.42	7.07	11.25	3.86	1.93	1.93	1.61	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	70.01	19.66	34.83	3.45	5.17	5.17	4.83	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	12.64	10.11	2.53	2.53	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.29	8.02	7.80	2.67	0.89	0.67	2.23	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	32.18	5.50	11.85	4.23	0.42	4.23	2.54	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	90.91	10.68	35.13	9.02	5.22	3.80	5.22	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.47	3.86	7.73	1.29	1.72	0.00	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	18.06	9.03	0.00	9.03	18.06	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.66	4.00	9.66	4.00	2.00	1.67	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.98	4.06	4.96	0.90	0.45	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.46	2.78	5.95	1.98	1.59	1.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	86.36	11.14	35.29	10.22	0.00	4.64	14.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.92	3.41	9.84	2.65	2.27	1.51	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	4.89	9.45	1.63	0.65	0.65	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	4.79	4.79	3.49	1.74	0.44	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	2.71	4.07	1.36	1.81	0.45	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	23.81	5.29	7.94	1.76	1.76	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.18	7.31	21.28	8.64	1.99	2.66	3.32	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.31	8.43	7.44	1.98	0.50	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	6.51	8.04	2.68	0.77	1.91	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.11	11.19	9.07	3.93	3.02	3.02	0.60	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.81	5.97	3.76	1.11	0.00	0.88	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	1.36	5.42	0.68	0.00	2.03	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	15.33	15.33	5.11	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.78	7.93	7.93	0.61	3.05	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.02	3.15	5.35	1.57	1.57	1.26	0.94	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.33	5.15	5.75	2.72	1.82	0.91	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	27.69	4.75	2.37	1.58	0.00	0.79	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	4.53	7.94	2.27	5.67	3.40	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	5.06	5.06	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	41.86	10.81	13.04	3.60	0.99	2.73	1.61	0.12	0.25
Myoblast, donor2	11322-117D8	40.08	11.32	6.33	2.69	1.53	1.53	0.96	0.19	0.00
Myoblast, donor3	11398-118D3	48.77	16.31	12.61	3.36	2.02	1.68	1.01	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.09	6.28	3.06	1.46	0.44	0.44	0.29	0.29	5.40
Natural Killer Cells, donor1	11230-116C6	101.79	27.68	4.61	7.69	0.31	1.85	3.08	1.23	16.61
Natural Killer Cells, donor2	11311-117C6	77.80	27.74	3.32	6.33	0.60	0.90	2.71	1.21	12.97
Natural Killer Cells, donor3	11387-118C1	71.97	25.22	3.13	7.91	1.29	0.37	1.66	1.10	11.96
Neural stem cells, donor1	11275-116H6	49.72	16.70	15.97	3.99	6.90	4.72	2.18	0.36	0.00
Neural stem cells, donor2	11352-117H2	32.74	19.26	11.55	5.78	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	12.52	7.97	9.10	0.00	2.28	2.28	1.14	1.14	0.00
Neurons, donor2	11574-120E8	18.49	7.05	6.38	1.10	1.10	2.20	0.44	0.00	0.00
Neurons, donor3	11655-122E8	10.69	5.76	7.40	3.29	1.64	3.29	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	24.13	7.42	2.78	7.42	1.86	0.00	0.00	3.71	0.00
Neutrophils, donor2	11314-117C9	26.09	14.49	0.00	0.00	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	89.79	31.15	6.72	12.22	1.83	1.22	0.00	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	64.00	24.10	15.55	5.94	5.94	5.70	3.80	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	28.65	12.70	9.12	4.56	2.28	0.65	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	17.65	11.23	4.41	1.80	0.80	0.60	1.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	56.30	14.73	22.85	9.50	3.85	3.85	0.96	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	69.04	15.63	24.61	7.96	3.04	3.04	2.17	2.03	0.00
Olfactory epithelial cells, donor3	11935-125I9	40.75	14.76	11.01	3.06	2.50	2.72	0.68	0.57	0.00
Olfactory epithelial cells, donor4	11936-126A1	97.11	24.35	22.01	10.91	5.65	6.04	2.92	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	81.85	25.28	16.85	4.81	4.21	1.81	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	35.95	12.12	8.30	4.68	1.06	1.91	0.85	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	12.57	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	17.38	1.24	3.72	2.48	0.00	1.86	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	24.04	8.79	7.23	1.56	1.17	2.35	1.17	0.20	0.00
Osteoblast, donor2	11354-117H4	75.15	14.05	7.02	2.81	3.51	4.21	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	64.16	20.08	13.69	5.33	2.13	2.31	1.96	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	128.88	31.17	24.18	13.14	6.40	5.22	5.31	1.01	0.08
Pericytes, donor1	11491-119E6	6.56	5.01	2.00	0.56	0.11	0.56	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	3.62	2.04	0.68	0.68	0.23	0.45	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	18.72	6.51	3.05	1.83	1.02	0.41	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	26.11	13.34	3.73	2.26	1.92	1.24	0.11	0.11	0.00
Perineurial Cells, donor2	11579-120F4	36.90	19.23	8.28	3.68	2.30	1.10	0.28	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	43.35	17.53	2.23	2.55	1.59	0.32	0.32	0.32	4.14
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.83	12.00	0.49	1.47	0.73	0.00	0.00	0.00	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	37.27	18.12	1.94	2.33	0.65	0.52	1.68	0.26	5.69
Placental Epithelial Cells, donor1	11278-116H9	66.73	11.24	8.61	2.87	0.72	1.43	0.24	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	66.53	14.42	6.65	0.00	2.22	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	39.46	14.53	7.46	1.77	1.37	1.96	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.35	3.48	2.53	1.58	0.32	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	28.14	3.75	3.94	3.75	1.13	1.69	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	35.37	12.92	5.87	3.79	2.35	1.17	0.52	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	15.31	8.78	1.35	2.48	0.23	0.68	0.23	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	54.56	8.31	9.27	4.58	1.70	1.81	0.64	0.64	0.00
Preadipocyte - omental, donor2	11329-117E6	51.07	16.15	9.60	3.93	3.06	1.75	1.75	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	40.97	13.47	12.18	4.01	1.15	1.43	0.72	0.72	0.14
Preadipocyte - perirenal, donor1	11469-119C2	35.43	10.83	2.95	4.92	0.00	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.36	6.14	3.38	0.31	0.31	1.54	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	36.83	10.98	5.67	4.43	1.42	2.66	1.42	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	18.22	5.96	3.75	1.53	1.02	1.19	1.02	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	101.72	17.05	25.52	8.85	4.94	4.84	3.26	0.65	0.00
Preadipocyte - visceral, donor2	11357-117H7	28.07	14.73	4.14	1.84	0.00	2.76	2.30	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	51.41	16.82	14.94	5.64	2.19	1.57	1.67	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2.56	3.77	0.30	0.00	0.15	0.15	0.00	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	16.25	6.09	1.49	1.35	0.27	0.41	0.00	0.41	0.00
Prostate Epithelial Cells, donor3	11404-118D9	22.66	6.74	0.98	1.59	0.18	0.31	0.06	0.31	0.06
Prostate Stromal Cells, donor1	11254-116F3	43.62	9.80	6.49	4.67	1.71	1.59	1.25	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	27.25	9.32	5.56	3.59	1.26	1.08	0.54	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	27.42	11.37	6.26	1.77	1.46	0.94	0.52	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.85	5.11	1.82	1.09	0.00	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.58	16.43	1.73	2.22	1.04	0.83	0.28	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	15.72	8.12	1.52	0.51	0.51	0.51	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	8.54	1.42	1.42	2.13	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	34.41	12.60	1.48	1.48	1.27	0.11	0.53	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	2.72	4.09	0.00	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.31	9.97	4.72	1.21	0.54	0.94	0.40	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	40.41	20.42	7.99	1.33	1.33	2.44	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.30	3.33	3.99	0.00	2.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.25	9.02	2.64	0.88	1.32	1.32	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	18.81	8.78	1.88	0.63	0.63	1.88	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	3.61	1.39	0.55	0.28	0.28	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.06	8.86	1.61	1.61	0.00	0.81	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	5.06	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.92	7.91	2.12	1.35	1.16	0.39	0.00	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	41.74	17.37	3.11	2.85	1.04	1.04	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.98	13.64	8.24	1.71	1.42	0.85	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	6.17	1.03	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.59	4.52	1.25	0.75	1.76	1.00	0.75	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	48.24	17.11	4.14	3.34	1.47	0.80	0.94	0.53	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	8.04	0.89	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	4.40	0.00	0.55	1.10	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.80	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	5.20	4.29	0.13	0.26	0.13	0.00	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.66	4.57	0.10	0.10	0.40	0.20	0.00	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	4.02	3.46	0.56	0.45	0.45	0.11	0.11	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.58	8.43	0.25	0.37	0.25	0.12	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	3.61	4.78	0.23	0.12	0.12	0.12	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	3.47	4.39	0.46	0.46	0.00	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	4.79	6.71	0.14	0.55	0.14	0.27	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	3.03	5.29	0.30	0.30	0.00	0.15	0.00	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2.51	3.94	0.00	0.18	0.18	0.00	0.00	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	6.03	9.47	0.29	0.14	0.29	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	3.54	4.40	0.11	0.43	0.21	0.00	0.00	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	3.10	2.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	3.82	5.93	0.57	0.38	0.00	0.19	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	4.84	4.19	0.75	0.19	0.28	0.19	0.09	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	5.26	4.32	0.00	0.00	0.94	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	5.04	6.24	0.53	0.13	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	3.99	4.19	0.19	0.10	0.29	0.10	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2.86	3.06	0.19	0.38	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	3.52	5.45	0.32	0.21	0.11	0.00	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	3.36	3.64	0.56	0.00	0.28	0.00	0.00	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	2.91	2.22	0.17	0.17	0.34	0.00	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.01	6.20	0.55	0.00	0.00	0.00	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	3.80	5.03	0.25	0.12	0.12	0.25	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	3.36	4.16	0.40	0.00	0.13	0.27	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.66	6.84	0.24	0.24	0.00	0.24	0.00	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	2.78	4.96	0.00	0.00	0.00	0.00	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1.64	4.44	0.00	0.23	0.23	0.00	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.56	6.22	0.41	0.00	0.00	0.00	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	4.65	3.10	0.66	0.00	0.00	0.00	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	2.92	4.39	0.42	0.21	0.00	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	5.52	6.19	0.67	0.40	0.00	0.00	0.00	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	3.24	3.75	0.85	0.17	0.51	0.34	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	3.66	2.89	0.00	0.19	0.00	0.00	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.39	9.11	0.52	0.00	0.17	0.17	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	4.39	5.08	0.41	0.27	0.55	0.14	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	2.79	3.94	0.16	0.00	0.16	0.00	0.00	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.28	8.01	0.51	0.51	0.17	0.17	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	2.66	5.92	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	5.86	6.66	0.27	0.27	0.00	0.53	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	2.63	5.12	0.00	0.28	0.00	0.00	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	3.10	4.29	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	3.02	8.06	0.00	0.40	0.81	0.00	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	3.96	5.65	0.19	0.28	0.09	0.00	0.00	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2.45	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1.81	3.63	0.00	0.60	0.30	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	3.18	7.96	0.37	0.12	0.00	0.00	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.15	8.01	0.29	0.58	0.29	0.44	0.00	0.15	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	3.04	4.87	0.00	0.00	0.00	0.00	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.82	6.33	0.30	0.00	0.00	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	5.88	5.88	0.68	0.45	0.23	0.00	0.00	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	4.49	7.49	0.00	0.00	0.30	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	4.13	5.20	0.00	0.00	0.00	0.12	0.12	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.12	5.55	0.21	0.00	0.21	0.00	0.00	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	6.01	12.02	0.60	0.00	0.60	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	14.48	7.52	2.44	0.56	0.00	0.56	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	23.82	13.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.57	12.93	4.60	1.53	0.66	1.31	0.44	0.22	0.00
Sebocyte, donor1	11220-116B5	21.36	7.12	0.55	1.64	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	8.73	5.97	0.46	0.00	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	8.04	2.47	1.65	1.03	0.21	0.41	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	41.41	4.97	18.22	6.63	1.66	1.66	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	96.03	2.82	22.59	11.30	8.47	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.11	5.10	2.64	1.67	0.97	0.88	0.62	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.06	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	25.92	10.03	2.51	3.34	0.84	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	48.23	18.69	12.57	3.46	1.89	1.73	1.10	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	46.97	16.80	9.81	4.31	0.89	1.78	1.34	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	36.94	13.08	4.62	3.08	0.92	1.08	0.62	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	84.55	18.02	15.12	7.94	3.53	3.78	3.15	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	66.78	23.97	14.70	7.56	3.42	2.43	3.14	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.30	21.73	8.83	4.07	2.18	0.79	1.19	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.12	4.30	3.45	0.76	1.01	0.59	0.51	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	5.79	3.62	2.17	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.08	10.04	11.97	1.51	1.79	1.24	0.69	0.41	0.00
Skin - palm, donor1	10286-104F7	40.29	8.06	8.06	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.21	2.16	0.14	0.72	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	9.81	2.45	7.36	0.82	1.64	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.35	2.47	0.39	0.78	0.13	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	32.39	7.23	2.92	2.92	0.83	0.42	0.14	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	9.85	4.78	1.13	1.97	0.42	0.56	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	48.84	18.18	3.38	3.59	0.85	0.63	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	16.56	5.62	1.12	1.80	0.30	0.15	0.37	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.75	7.10	5.25	1.85	0.00	1.23	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	148.74	38.91	44.91	8.23	4.89	6.23	4.45	0.89	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	37.62	9.99	8.82	4.11	0.59	1.76	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	45.97	7.51	8.18	7.96	0.44	1.77	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	53.16	9.06	29.14	3.54	1.18	3.94	1.58	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.90	8.50	6.95	6.18	0.77	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	17.01	6.00	3.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	40.32	7.59	8.78	3.99	0.93	2.13	0.80	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	69.82	18.40	12.63	8.42	1.77	1.77	1.99	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.45	4.99	12.42	2.18	1.41	1.79	0.38	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.91	10.09	2.93	1.95	0.65	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.14	13.29	11.52	3.84	2.07	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.03	14.81	12.39	2.70	2.14	1.57	1.14	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.00	6.51	5.69	1.46	0.81	1.14	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	54.80	17.05	5.18	3.96	2.13	2.44	1.52	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	88.40	18.69	16.42	7.32	2.02	3.03	3.03	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	30.60	6.12	0.00	0.00	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	26.70	4.77	4.29	1.91	0.48	1.43	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.40	9.59	5.31	3.10	1.62	1.18	1.47	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	40.03	13.56	11.41	3.44	1.51	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.66	13.54	4.93	2.62	0.84	1.05	0.21	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	50.73	9.90	20.88	3.56	2.63	3.71	1.70	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	33.41	9.70	11.86	1.08	2.16	4.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.03	4.48	3.89	2.39	0.30	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	3.41	1.71	0.68	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	42.56	13.74	7.70	4.32	2.67	1.88	1.65	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	200.58	41.56	45.49	14.29	6.14	7.75	6.74	3.93	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.88	14.34	17.29	5.92	1.59	3.41	1.59	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	32.61	7.25	5.43	0.00	0.00	0.60	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.72	11.66	2.91	1.85	0.79	0.53	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.55	12.52	7.86	2.13	1.07	1.20	0.53	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.43	9.02	9.89	2.88	2.00	1.75	0.88	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	73.05	16.23	13.70	6.09	1.78	1.27	1.78	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	96.49	19.60	51.11	6.18	7.69	8.14	4.98	0.90	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.76	8.25	14.25	6.75	1.50	1.50	3.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	146.02	6.46	10.34	31.01	0.00	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.16	8.84	2.33	2.79	1.86	0.47	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	57.05	12.62	21.21	7.57	1.01	1.51	1.01	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	57.35	14.73	36.35	5.95	0.94	3.13	2.51	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.70	5.01	3.54	0.88	0.00	0.29	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	34.99	13.75	7.25	2.42	1.58	1.00	0.92	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	40.18	15.42	8.88	3.27	3.74	4.20	1.87	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	49.08	8.64	9.93	4.61	1.58	2.16	2.01	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	54.56	9.94	15.04	3.82	1.78	2.55	1.27	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.93	7.15	4.14	2.07	0.38	0.56	0.38	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.29	19.14	6.85	3.49	2.10	1.54	1.68	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	64.52	21.37	15.84	4.52	1.76	2.60	1.34	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.95	0.00	0.48	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	44.28	13.70	9.05	3.18	1.47	1.47	2.20	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	67.83	13.48	70.04	5.08	3.54	7.95	1.10	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	58.52	17.55	8.78	6.14	3.22	1.76	1.46	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	63.75	11.47	6.80	4.08	1.17	2.14	1.94	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	101.02	13.22	40.46	7.93	4.23	6.08	4.50	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	97.45	14.51	46.12	10.79	6.70	8.93	7.07	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	138.34	17.97	55.34	15.45	7.19	12.58	6.11	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	176.30	14.76	132.58	11.36	6.53	12.78	5.96	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	104.38	13.00	25.21	6.70	1.97	3.15	4.73	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	103.36	12.44	60.95	9.90	3.81	8.38	7.11	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	75.07	15.17	24.36	6.39	3.19	5.19	3.99	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.13	9.20	30.93	5.02	3.76	7.94	3.34	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	64.63	8.71	23.38	1.38	0.46	3.21	2.29	0.46	0.00
Synoviocyte, donor1	11291-117A4	162.26	19.53	36.02	18.68	4.88	7.91	6.73	1.18	0.00
Synoviocyte, donor2	11368-117I9	44.92	8.72	11.90	4.19	1.17	2.68	5.36	0.17	0.00
Synoviocyte, donor3	11440-118H9	45.80	9.16	6.26	4.47	0.67	0.45	3.80	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	15.01	7.50	2.14	0.36	0.00	0.71	0.36	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.03	4.40	1.85	1.16	0.69	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.34	4.87	0.79	0.22	0.29	0.14	0.14	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	6.19	1.55	1.16	0.77	0.00	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	2.86	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	50.56	16.24	3.57	2.71	2.21	0.62	0.74	0.74	0.00
Urethra, donor2	10319-105A4	46.76	23.38	3.60	0.00	5.40	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	12.49	3.98	1.59	0.80	0.27	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	16.02	5.21	2.00	1.20	0.80	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	20.40	4.81	1.38	1.83	0.00	0.46	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	47.03	14.71	1.34	2.90	1.11	0.45	0.67	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	56.06	24.02	0.00	3.56	0.00	0.00	0.00	1.78	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	60.04	31.45	0.00	4.29	1.43	0.00	0.00	1.43	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	43.12	23.27	2.74	2.74	0.68	0.00	0.00	0.68	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	45.45	15.50	3.44	4.82	1.03	0.34	2.07	2.41	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	48.23	13.36	2.91	4.07	1.74	2.32	0.00	0.00	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	48.94	23.95	2.08	4.16	3.12	1.04	1.04	1.04	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	74.34	23.86	5.51	4.59	0.00	0.92	1.84	0.00	9.18
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	18.26	2.74	2.74	0.91	0.00	0.91	1.83	5.48
Wilms' tumor cell line:G-401	10809-111A8	3.58	5.92	1.97	0.12	0.99	0.99	0.12	1.11	0.00
Wilms' tumor cell line:HFWT	10597-108E3	32.56	16.72	19.36	3.52	2.64	6.16	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.52	10.89	2.51	1.12	0.84	0.00	0.00	0.28	0.00
achilles tendon, donor2	10292-104G4	16.53	10.33	8.27	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	9.18	9.69	1.02	0.00	1.02	0.51	0.00	0.25	4.08
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.39	4.18	0.23	0.00	0.00	0.00	0.00	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.55	6.17	1.07	0.36	0.83	0.00	0.00	0.24	7.48
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	81.36	33.20	16.05	3.54	4.90	3.27	3.54	0.54	4.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	47.78	28.11	16.30	3.94	6.46	3.37	0.84	0.28	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.70	30.03	11.84	6.98	4.23	2.75	1.06	0.85	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.54	20.14	4.90	4.63	2.18	0.82	0.27	0.27	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.53	7.05	0.00	0.00	1.32	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.39	22.46	6.13	2.86	0.82	0.82	0.82	0.41	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	70.67	36.50	18.25	5.44	5.05	1.94	0.39	0.00	4.27
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.62	12.33	0.74	0.55	0.18	0.55	0.00	0.55	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	15.60	0.00	0.00	3.90	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.03	21.84	9.06	1.63	3.49	2.56	0.23	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	30.55	17.35	0.52	1.29	1.04	0.00	0.52	0.00	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.90	11.11	0.29	0.58	0.29	1.46	0.00	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	16.27	1.39	1.86	0.46	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.47	15.63	2.47	2.47	0.82	0.82	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.64	18.11	1.53	0.31	0.92	0.92	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.55	30.72	2.56	2.13	1.28	0.85	0.00	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	42.16	40.34	2.73	1.52	1.21	0.30	0.30	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	34.66	31.77	2.17	0.48	1.20	0.00	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.26	10.02	5.35	0.89	1.78	0.89	0.22	1.34	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	5.57	0.00	1.86	1.86	1.86	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	18.08	29.00	4.14	0.38	1.51	2.64	0.38	0.00	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	54.95	47.97	14.83	2.62	3.93	6.98	0.00	0.44	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	16.87	5.62	11.25	0.00	5.62	0.00	0.00	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	6.59	12.01	0.24	0.24	0.00	0.00	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	114.79	23.89	13.50	7.76	2.02	2.17	1.86	1.09	0.31
adipose, donor1	10184-103D4	5.86	13.49	0.00	0.59	1.76	0.00	0.00	0.59	0.00
adipose, donor2	10185-103D5	4.46	7.70	2.03	0.00	1.62	2.03	0.00	0.41	0.00
adipose, donor3	10186-103D6	5.99	10.89	3.00	0.27	2.72	1.91	0.27	1.09	0.00
adipose, donor4	10187-103D7	44.20	8.67	1.73	4.33	1.73	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1.26	4.42	0.32	0.00	0.47	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	29.10	3.64	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	35.09	22.95	0.53	1.73	0.00	0.13	0.13	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.01	7.50	1.79	1.07	0.71	0.00	0.36	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	160.44	67.00	10.43	18.55	2.32	2.32	0.70	0.46	0.93
amniotic membrane cells, donor2	12236-129G4	122.39	40.91	13.86	6.42	3.38	4.40	1.69	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	182.95	78.95	10.31	8.84	2.36	3.54	0.88	0.59	0.59
amygdala - adult, donor10196	10167-103B5	124.51	71.15	17.79	16.60	3.56	0.00	7.11	1.19	0.00
amygdala, adult, donor10252	10151-102I7	133.02	111.52	11.35	13.38	4.87	2.84	7.91	0.41	0.41
amygdala, newborn, donor10223	10360-105E9	89.08	35.18	20.01	7.75	5.16	4.20	4.20	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	15.02	5.60	1.53	1.02	0.89	0.13	0.25	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	114.06	21.40	7.28	15.88	1.76	1.10	0.66	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.00	5.68	0.00	0.00	0.00	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	76.69	32.95	12.75	9.81	3.53	2.75	4.90	0.39	0.00
appendix, adult	10189-103D9	79.56	21.73	9.31	5.05	1.16	1.55	7.37	0.39	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.97	18.92	2.75	0.34	0.69	0.34	0.00	0.69	1.38
artery, adult	10190-103E1	40.76	10.87	4.08	5.43	0.00	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	72.72	25.93	17.53	3.19	3.91	2.32	0.43	0.29	0.00
b cell line:RPMI1788	10427-106D4	1.49	1.34	0.15	0.30	0.00	0.00	0.00	13.23	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	256.36	43.84	87.12	22.75	12.76	13.04	10.54	2.22	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	5.76	3.18	0.10	0.69	0.00	0.10	0.00	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	4.02	3.01	0.00	0.17	0.00	0.00	0.00	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	8.39	10.07	0.00	0.56	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	158.83	35.63	25.10	14.34	5.32	3.91	17.49	2.39	0.11
blood, adult, pool1	10053-101G8	13.29	13.29	0.00	0.00	0.00	0.00	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	69.36	30.83	12.85	9.42	3.43	0.00	5.99	0.00	0.00
bone marrow, adult	10192-103E3	60.06	15.52	4.72	3.37	2.02	1.35	0.67	1.35	0.00
brain, adult, donor1	10084-102B3	35.88	31.78	10.25	5.13	2.05	1.03	5.13	0.00	0.00
brain, adult, pool1	10012-101C3	51.34	34.97	5.90	7.24	3.79	1.67	3.45	1.22	0.22
brain, fetal, pool1	10085-102B4	18.70	24.04	2.67	5.34	2.67	0.00	10.69	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	1.98	2.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	14.23	19.10	1.25	1.00	1.50	0.12	0.12	0.12	0.00
breast, adult, donor1	10080-102A8	47.35	15.78	12.00	3.16	0.00	1.26	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.84	4.70	0.76	0.13	0.25	0.13	0.13	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	7.11	1.86	0.62	1.55	0.62	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.12	9.44	1.15	0.69	1.61	0.69	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.22	14.04	2.42	0.24	0.97	0.48	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.99	26.80	1.88	0.00	0.47	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	4.81	8.42	0.55	0.22	0.11	0.00	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	5.70	4.75	1.90	0.00	0.32	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.82	14.37	10.38	0.53	2.66	1.60	0.53	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	21.88	23.03	11.51	2.30	2.30	2.30	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.52	40.83	7.20	4.85	2.68	1.84	5.86	0.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	18.34	7.64	3.06	0.76	0.00	0.76	3.06	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	34.06	8.79	11.35	4.39	1.10	2.56	2.93	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	29.13	29.13	11.65	2.91	5.83	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	51.88	47.61	5.12	3.63	1.28	1.49	2.56	0.43	0.00
cerebellum, adult, pool1	10083-102B2	14.14	16.56	3.45	1.38	0.00	0.34	1.03	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	39.02	16.61	8.30	1.66	4.15	4.98	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	55.22	36.31	6.56	7.31	2.27	1.76	2.27	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	10.23	5.12	1.46	0.00	0.00	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	1.87	1.01	0.43	0.00	0.00	0.00	0.00	13.08	0.00
cervical cancer cell line:ME-180	10553-107I4	105.89	28.34	10.44	5.97	1.99	2.15	0.17	0.17	0.17
cervix, adult, pool1	10013-101C4	205.26	53.65	37.90	19.00	9.03	7.03	15.01	2.41	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.50	2.79	0.14	0.70	0.14	0.14	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	13.06	6.53	5.23	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	68.97	34.92	17.27	3.11	6.46	2.49	0.25	1.74	0.00
choriocarcinoma cell line:SCH	10785-110H2	14.29	13.31	7.15	0.25	2.71	1.85	0.12	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	24.90	42.22	6.40	1.19	2.13	1.19	0.00	6.40	0.00
chorionic membrane cells, donor1	12238-129G6	82.63	34.19	4.56	6.27	2.56	0.85	0.00	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	37.39	17.90	7.76	2.78	1.39	1.39	0.20	0.20	0.00
chorionic membrane cells, donor3	12240-129G8	59.89	31.87	6.59	7.14	1.10	0.55	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	28.27	5.05	8.08	2.02	3.03	1.01	1.01	0.00	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.12	17.10	7.49	3.07	1.54	2.31	0.38	0.00	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	25.98	25.13	4.43	1.06	0.21	1.27	0.00	0.42	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.31	4.62	0.00	0.26	0.00	0.00	0.00	5.91	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.18	4.11	0.00	0.00	0.24	0.00	0.00	6.29	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.04	6.72	0.20	0.41	0.00	0.00	0.00	5.09	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.88	0.88	0.00	0.00	0.00	0.00	0.00	1.77	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	34.40	15.90	3.13	2.61	0.26	0.00	0.26	0.78	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	1.37	2.74	0.00	0.23	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	1.56	1.74	0.00	0.35	0.00	0.00	0.00	1.56	0.00
colon carcinoma cell line:CACO-2	10513-107D9	1.65	10.43	0.00	0.18	0.18	0.00	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	0.38	7.60	0.76	0.00	0.38	0.00	0.00	2.28	0.00
colon, adult, donor1	10082-102B1	163.03	30.94	33.32	10.71	2.38	8.33	15.47	0.00	0.00
colon, adult, pool1	10014-101C5	135.60	27.85	16.80	9.05	4.11	4.47	7.29	1.06	0.35
colon, fetal, donor1	10070-101I7	66.74	16.07	19.78	6.80	1.85	4.33	5.56	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	55.00	59.59	27.50	0.00	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	5.95	2.97	0.00	0.00	0.00	0.42	0.00	5.52	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.04	6.64	0.00	0.30	0.00	0.00	0.00	1.81	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	7.90	8.74	0.00	0.42	0.28	0.00	0.00	1.83	0.56
corpus callosum, adult, pool1	10042-101F6	45.22	26.76	12.83	4.42	2.87	2.10	8.07	0.22	0.22
cruciate ligament, donor2	10295-104G7	67.27	8.10	10.54	7.29	3.24	1.62	1.62	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	61.80	22.47	16.05	4.01	5.62	3.21	3.21	0.00	0.00
diencephalon, adult	10193-103E4	13.44	10.08	5.04	0.48	1.20	0.72	1.68	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.92	2.30	0.00	0.00	0.00	0.23	0.00	25.03	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	24.62	10.26	1.28	0.77	1.03	0.26	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.89	10.59	11.55	1.44	1.44	2.89	0.24	0.48	0.24
ductus deferens, adult	10196-103E7	78.74	24.42	9.47	5.98	2.49	2.99	1.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	17.28	8.64	1.44	2.88	1.44	2.88	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	87.54	23.54	11.03	7.36	4.41	4.41	7.36	0.74	0.00
dura mater, adult, donor1	10041-101F5	66.81	20.07	22.46	9.41	3.88	4.54	4.05	0.17	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2.22	1.11	0.00	0.00	0.00	0.00	0.00	13.77	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.73	5.88	0.57	0.29	0.00	0.00	0.00	3.73	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	6.78	0.62	1.85	0.62	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	18.47	10.29	1.82	0.61	0.91	0.61	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.99	14.20	2.78	0.31	0.31	0.00	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	18.39	1.31	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	0.67	2.35	0.67	0.00	0.34	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	34.43	20.48	6.71	2.54	1.81	1.99	0.72	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	26.37	16.08	3.86	0.80	3.06	1.93	0.00	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	58.36	12.45	6.67	4.67	1.33	1.22	0.56	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.22	6.60	1.10	1.87	0.66	0.22	0.00	0.22	0.00
epididymis, adult	10197-103E8	77.65	20.09	14.02	5.86	1.47	2.09	3.35	1.67	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	83.56	24.13	65.46	8.34	12.42	9.58	5.32	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.80	4.33	1.18	0.39	0.39	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.04	16.91	3.41	3.01	1.18	0.39	0.13	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.94	17.22	3.44	1.97	0.89	0.69	0.30	0.69	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.76	16.47	3.70	2.02	1.34	0.67	0.22	0.22	0.00
esophagus, adult, pool1	10015-101C6	102.67	24.21	11.15	9.98	3.08	2.76	9.24	1.27	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.26	4.88	0.75	0.50	0.38	0.25	0.00	0.63	0.00
eye - muscle inferior rectus, donor1	10272-104E2	62.78	14.49	9.66	0.00	2.41	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	4.21	2.10	0.00	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	40.18	14.88	11.91	1.49	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	38.98	14.90	14.90	0.00	3.44	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	7.29	2.91	1.46	5.83	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	28.22	20.08	9.92	2.29	2.54	1.53	1.53	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	6.03	2.82	0.13	0.13	0.00	0.26	0.38	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	5.46	4.51	0.71	0.71	0.47	0.00	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	78.81	53.76	11.26	8.26	5.63	2.63	4.41	0.38	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	129.41	33.93	24.62	4.80	4.20	3.60	1.50	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.24	7.95	0.09	0.55	0.09	0.09	0.09	0.09	0.00
gall bladder, adult	10198-103E9	76.53	20.28	8.69	10.38	2.41	1.45	5.31	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	182.53	31.14	10.74	10.74	0.54	3.22	2.15	0.54	20.94
gamma delta positive T cells, donor2	11938-126A3	109.43	32.12	5.23	6.72	4.86	1.49	2.99	0.75	21.29
gastric adenocarcinoma cell line:MKN1	10614-108G2	58.30	19.43	5.91	4.86	1.27	2.11	0.63	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.42	11.99	1.74	0.19	0.39	0.19	0.19	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	0.49	3.44	0.82	0.00	0.82	0.16	0.00	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	0.00	0.92	0.00	0.00	0.00	0.00	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3.66	7.77	0.46	0.00	0.00	0.23	0.00	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.08	1.84	0.11	0.34	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	8.40	8.68	0.42	0.42	1.12	0.42	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	33.17	10.72	2.99	2.49	0.50	0.50	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.80	16.78	9.71	3.69	2.96	2.74	2.43	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.95	16.29	8.43	4.35	3.65	2.81	0.98	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	12.14	10.82	3.20	0.88	1.55	0.99	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	161.38	30.17	43.64	13.18	6.74	4.10	2.64	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	31.34	13.85	14.58	1.46	0.73	0.73	5.83	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	42.72	29.29	7.81	4.64	2.69	0.73	5.61	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	42.45	19.17	2.74	2.74	0.00	4.11	10.95	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	25.58	9.59	3.73	3.73	2.66	0.53	5.33	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	29.37	17.13	7.34	4.89	4.89	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	138.56	35.20	40.32	12.48	6.72	6.40	5.12	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	11.48	18.82	12.40	0.00	1.84	2.75	0.00	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	10.97	22.86	14.18	1.37	1.83	1.83	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	23.19	15.46	9.66	1.29	3.22	1.93	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	14.37	14.37	2.87	0.00	0.00	1.44	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	2.74	13.03	4.80	0.00	0.00	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	27.59	29.79	4.41	4.41	0.00	2.21	9.93	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	4.60	8.91	0.29	0.29	0.00	0.00	0.00	0.86	6.32
heart - mitral valve, adult	10205-103F7	82.52	26.31	15.85	7.47	2.39	3.29	3.59	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	113.22	29.29	14.64	6.80	3.14	3.40	6.01	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	59.12	8.33	9.99	4.16	2.50	1.67	3.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	58.97	23.67	22.45	4.49	2.45	3.06	1.84	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	92.83	45.99	24.27	8.94	4.26	5.54	0.43	1.28	0.43
heart, adult, pool1	10016-101C7	56.11	18.86	12.19	3.68	1.61	2.07	1.61	0.23	0.23
heart, fetal, pool1	10046-101G1	191.19	63.46	43.84	7.60	11.60	6.98	1.54	0.31	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	88.85	21.60	22.21	7.40	4.63	1.23	2.78	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.34	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.12	0.12	0.00	0.00	0.00	0.00	0.00	17.36	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.40	0.00	0.00	0.00	0.00	0.00	17.08	0.00
hepatoma cell line:Li-7	10484-107A7	15.35	8.79	1.89	0.56	0.33	0.11	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.70	1.61	0.10	0.00	0.00	0.00	0.00	17.79	0.00
hippocampus - adult, donor10196	10169-103B7	67.19	35.96	17.03	11.36	6.62	4.73	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	80.62	61.23	10.00	8.16	4.49	2.45	8.78	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	91.12	48.30	7.97	5.98	1.49	2.99	3.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	22.56	9.52	7.75	2.11	1.06	0.00	0.70	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.05	19.53	0.61	0.00	0.61	1.83	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.14	7.85	1.96	0.00	1.57	0.59	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.54	13.96	2.54	0.25	1.02	0.76	0.00	0.51	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.69	21.43	2.26	0.00	2.26	1.69	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.87	22.46	3.10	0.00	3.10	0.52	0.26	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.04	21.64	1.90	0.00	2.66	2.66	0.38	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.13	14.60	3.80	0.29	1.46	2.34	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	6.25	15.73	3.88	0.00	2.59	0.86	0.43	1.72	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	9.18	4.59	0.42	2.09	0.83	0.00	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.26	12.55	4.03	0.24	2.60	0.24	0.24	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	11.89	14.30	4.82	0.64	2.41	1.77	0.32	0.80	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	15.49	12.12	9.43	1.35	3.37	2.02	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.10	5.95	2.19	0.16	1.10	0.94	0.00	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	5.40	0.49	0.00	0.98	0.49	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	7.85	1.75	0.00	2.62	1.75	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.72	12.22	1.34	0.00	1.91	1.15	0.00	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.49	8.29	1.31	0.00	0.44	1.74	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	4.00	10.99	2.00	0.50	2.00	1.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.65	13.38	5.27	1.32	3.77	1.70	0.19	1.32	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.28	18.19	4.55	0.00	2.27	1.36	0.45	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.89	12.84	3.13	0.00	5.95	2.19	0.31	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.96	11.27	3.43	0.82	1.47	0.98	0.82	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.03	10.74	4.35	0.58	0.87	1.45	0.00	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	14.65	9.57	3.29	0.60	2.99	2.39	0.60	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	3.14	10.72	2.40	0.18	1.85	0.18	0.18	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	2.28	9.13	3.42	0.00	0.86	2.57	0.00	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6.12	15.92	4.49	0.82	1.22	1.22	0.00	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	3.52	16.55	4.22	0.70	1.76	0.70	0.00	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	4.75	13.30	2.85	0.00	0.63	0.95	0.00	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	4.24	8.17	2.72	0.00	0.61	1.51	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.79	14.48	1.55	1.03	1.55	2.59	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.31	9.96	3.32	0.00	1.33	1.33	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.72	8.21	5.39	0.51	2.05	0.77	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.48	7.93	4.60	0.51	1.28	1.02	0.26	1.28	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	12.87	6.82	0.00	0.76	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.06	8.74	4.37	0.67	1.01	1.34	0.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	2.66	12.80	4.59	0.24	1.69	0.24	0.00	0.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	4.46	11.14	2.67	0.00	2.67	0.45	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	2.44	7.32	3.41	0.00	1.46	1.46	0.49	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.75	13.75	3.97	0.31	1.83	0.61	0.31	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	29.28	0.00	0.00	3.25	3.25	0.00	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	4.96	18.86	1.65	0.00	2.65	2.32	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.76	10.40	2.19	0.55	2.19	0.55	0.55	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.60	14.84	4.70	0.72	2.90	2.17	0.00	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.98	12.81	4.27	0.71	4.63	1.42	1.07	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	10.74	3.58	0.00	3.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.03	16.52	6.50	0.54	4.74	2.71	0.54	1.49	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	10.51	5.93	0.81	1.89	0.54	0.27	0.81	0.27
immature langerhans cells, donor1	11904-125F5	25.91	15.98	12.11	0.73	5.33	3.15	0.00	0.48	0.24
immature langerhans cells, donor2	11905-125F6	41.19	20.60	11.88	3.17	3.17	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	142.14	82.33	15.90	14.20	6.25	5.30	6.15	0.47	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	30.89	15.93	4.88	3.58	1.30	1.30	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	27.84	11.01	2.20	2.00	1.80	0.70	0.50	0.20	0.10
kidney, fetal, pool1	10045-101F9	35.72	22.00	3.61	1.91	2.33	0.71	0.28	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.50	9.23	4.54	1.14	2.56	0.99	0.43	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.49	1.80	0.14	0.00	0.00	0.00	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.99	3.85	0.37	1.28	0.18	0.18	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	45.77	16.89	17.44	3.81	1.09	2.72	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	55.62	14.66	14.16	3.03	1.01	1.01	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	19.15	6.57	42.96	2.46	3.83	6.29	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	89.09	18.32	73.29	6.11	7.54	9.34	6.47	2.51	0.00
leiomyoma cell line:15242A	10570-108B3	84.78	13.04	171.20	10.87	10.87	13.04	6.52	2.17	0.54
leiomyoma cell line:15425	10571-108B4	130.88	21.85	93.97	14.57	9.23	8.98	11.41	4.13	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	31.75	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.62	5.08	1.65	0.24	0.59	0.47	0.00	3.66	0.35
liposarcoma cell line:KMLS-1	10782-110G8	38.74	14.84	6.40	4.69	1.56	0.31	0.62	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	19.37	14.62	6.34	1.95	1.71	1.10	0.24	0.24	0.00
liver, adult, pool1	10018-101C9	59.31	24.15	7.94	3.24	1.78	1.94	0.49	2.27	0.00
liver, fetal, pool1	10086-102B5	14.11	8.47	3.76	0.94	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	40.25	30.19	9.33	4.08	2.04	1.31	6.12	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	48.17	43.55	6.83	3.32	1.85	1.29	5.54	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	32.45	30.19	11.29	6.77	2.82	1.41	8.75	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	59.73	20.61	11.36	5.05	2.10	2.10	7.99	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	2.21	4.01	0.14	0.42	0.42	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	15.17	1.38	0.69	1.38	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	16.87	11.34	3.03	1.32	2.64	0.66	0.26	0.26	0.00
lung, adult, pool1	10019-101D1	73.48	23.98	7.09	6.38	2.36	2.36	1.30	0.59	0.35
lung, fetal, donor1	10068-101I5	254.58	55.65	39.39	8.56	7.42	7.14	4.00	2.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	54.99	19.70	9.62	5.04	0.92	1.37	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	20.83	13.25	2.37	1.89	0.95	0.00	0.47	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.04	20.82	1.53	0.22	1.53	0.22	0.22	0.44	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.79	5.74	0.00	0.30	0.45	0.15	0.00	0.30	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.06	10.19	3.40	4.25	3.40	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	210.45	41.74	110.55	23.09	8.44	7.99	6.22	0.44	0.00
mature adipocyte, donor2	12232-129F9	205.66	36.52	61.84	19.72	5.81	7.89	4.57	0.83	0.00
mature adipocyte, donor3	12233-129G1	214.78	46.46	96.96	24.65	7.59	10.43	5.93	1.19	0.00
mature adipocyte, donor4	12234-129G2	118.18	30.01	51.59	12.90	6.05	7.90	3.95	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1.19	1.91	0.95	0.00	0.24	0.00	0.00	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	54.15	34.97	5.64	4.51	5.64	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	82.02	65.47	7.54	10.30	2.39	1.66	7.91	0.55	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	37.17	29.23	10.48	6.35	2.22	2.22	2.86	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	82.74	26.87	16.63	5.54	5.54	3.84	4.69	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	68.01	58.39	8.44	10.29	2.70	3.21	5.23	0.84	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	93.38	75.13	8.49	9.97	2.76	1.06	7.00	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	142.54	63.57	13.48	5.78	1.93	7.71	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	143.54	14.35	28.71	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	65.68	22.25	16.51	9.33	5.38	2.87	2.15	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	18.17	19.47	7.79	1.30	1.30	0.65	3.24	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	37.15	31.58	8.67	4.18	1.24	1.39	8.36	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	41.39	22.20	11.92	3.92	2.37	2.94	6.20	0.24	0.16
medulla oblongata, newborn, donor10223	10361-105F1	35.07	7.99	6.60	6.25	1.39	0.35	6.94	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	28.78	23.25	11.51	1.55	3.54	2.21	0.44	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	7.46	5.99	0.98	0.98	0.24	0.12	0.61	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	10.92	6.04	1.01	0.86	0.43	0.43	0.00	0.43	0.00
melanoma cell line:G-361	10465-106H6	19.27	10.04	1.90	0.54	0.54	1.36	0.27	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	51.92	10.67	1.63	2.71	0.18	0.18	0.72	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	30.84	18.50	0.88	3.52	0.88	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.81	37.59	14.00	1.04	3.63	2.07	0.26	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.44	16.11	7.52	3.53	1.38	0.92	0.61	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.63	7.09	3.09	2.18	0.55	0.55	0.73	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	121.75	22.36	31.89	7.45	2.07	2.90	4.56	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	61.53	20.51	17.00	7.16	1.83	1.55	3.79	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	62.01	21.76	25.23	8.47	2.12	3.08	4.04	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	113.83	23.60	48.59	18.05	4.86	12.49	13.88	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.44	7.72	5.66	2.92	1.03	1.03	0.17	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	115.13	35.08	42.79	11.39	2.07	3.80	5.87	0.58	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.52	6.37	2.25	0.80	0.40	0.40	0.40	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.62	17.96	10.80	5.94	0.95	2.03	1.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	29.16	19.06	9.67	2.42	1.71	2.42	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	3.29	0.33	0.66	0.00	0.33	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.99	11.48	5.12	1.52	1.38	0.55	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	57.60	17.45	6.28	4.19	2.79	2.09	2.09	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.32	13.47	7.15	4.49	1.43	1.22	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.21	9.71	11.14	2.88	1.08	0.36	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	87.83	21.62	40.45	10.76	4.97	3.93	2.17	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	158.23	23.03	275.41	15.50	16.87	20.98	7.30	4.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	132.16	43.21	52.44	9.65	2.52	3.36	4.62	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.97	11.66	4.03	1.64	0.45	0.60	0.75	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.17	14.79	11.03	3.06	1.40	1.40	0.61	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.70	11.04	12.52	4.05	1.10	1.10	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.38	18.31	17.17	3.72	2.86	1.72	1.43	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	26.52	8.00	2.53	1.26	0.00	0.42	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.38	21.46	7.31	5.02	0.91	0.46	2.28	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	63.69	15.60	9.98	4.60	1.02	2.56	2.05	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	64.39	17.01	9.95	6.02	1.31	2.36	2.62	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	60.69	14.48	11.71	5.55	2.77	1.23	3.39	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	65.19	15.30	11.06	5.41	2.12	1.18	4.47	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	62.95	17.60	11.17	7.78	1.35	2.71	3.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	68.77	19.65	11.40	6.29	1.18	2.36	2.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	69.97	9.73	8.34	7.88	0.46	1.39	1.85	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	85.08	21.92	17.31	7.79	3.46	2.60	1.73	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	71.39	15.84	9.82	7.59	2.68	2.68	2.23	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	68.74	19.47	9.37	4.57	2.16	1.44	3.85	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	88.00	28.60	17.60	13.20	2.20	2.20	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	66.80	17.12	10.74	7.38	1.01	3.02	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	77.37	17.60	8.60	5.73	1.23	4.91	2.05	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	77.75	14.18	11.17	6.44	3.87	4.30	1.29	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	71.09	5.47	10.94	5.47	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	20.66	10.33	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	74.70	15.91	10.72	6.17	1.95	0.97	1.62	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	69.84	20.37	7.27	4.36	1.45	1.45	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	64.50	9.06	16.53	7.46	1.07	3.73	1.60	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	57.24	12.27	15.54	4.91	2.45	4.09	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	64.92	17.10	15.94	5.05	2.33	4.28	2.33	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	48.27	6.30	4.20	4.20	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	67.56	5.96	13.91	4.97	1.99	6.95	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	9.53	9.53	9.53	4.77	9.53	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	55.15	12.45	9.49	5.93	0.59	3.56	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	68.23	9.75	12.18	7.31	1.22	2.44	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	63.34	12.03	14.57	5.70	1.27	1.27	2.53	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	6.21	6.90	4.48	0.34	2.41	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	6.45	8.60	0.00	0.00	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	0.00	0.00	3.99	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.60	7.33	7.33	2.85	0.81	2.04	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.13	5.56	8.74	6.36	1.59	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.78	12.38	7.66	2.36	0.00	1.77	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	48.00	10.91	8.42	3.43	0.62	1.87	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	70.84	13.37	13.37	6.68	0.00	4.01	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	69.78	15.37	11.83	4.73	1.18	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	12.84	17.98	10.27	0.00	5.14	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	69.53	15.83	19.96	8.26	0.69	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	82.63	22.76	28.70	10.39	3.46	3.46	0.99	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	78.51	22.43	39.25	8.97	2.24	7.85	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	83.32	17.81	34.98	8.27	3.18	3.82	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	63.27	14.51	37.48	7.25	1.21	2.01	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	21.81	43.61	8.72	4.36	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	62.09	12.67	39.28	2.53	2.53	8.87	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	56.44	21.24	15.17	3.03	0.61	2.43	0.00	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	18.08	40.67	4.52	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	50.24	13.18	18.12	6.59	0.00	1.65	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	58.14	12.10	27.78	9.52	2.38	3.77	1.19	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.00	13.30	23.36	3.24	1.95	1.95	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	50.93	14.26	23.43	7.13	0.00	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	10.83	3.09	3.09	1.55	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	70.64	26.46	14.65	4.49	2.60	2.13	1.18	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.35	12.97	17.84	2.09	3.71	1.85	0.70	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	29.49	6.37	4.21	4.32	0.62	1.34	1.34	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	5.45	1.36	0.45	0.45	0.45	0.45	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	45.23	11.25	5.38	6.36	2.69	1.22	0.73	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	38.97	12.62	5.98	1.77	1.77	0.89	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	10.25	2.10	1.05	1.31	0.26	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	12.77	3.74	2.89	1.53	0.68	1.02	1.02	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	42.47	13.90	21.49	1.52	5.06	4.04	0.51	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	26.29	8.28	5.59	2.69	2.07	1.04	0.83	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	75.20	11.26	8.61	4.80	0.99	1.99	0.66	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	15.20	3.26	1.81	0.90	0.18	0.54	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	26.31	6.66	3.93	2.39	1.37	0.68	1.37	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	1.27	2.29	0.25	0.00	0.25	0.00	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	5.87	3.26	0.33	0.33	0.00	0.00	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	13.01	3.25	0.81	0.81	0.54	0.00	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	3.65	2.30	0.38	0.19	0.00	0.19	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	6.23	4.03	0.24	0.37	0.37	0.24	0.00	0.00	0.61
migratory langerhans cells, donor3	11903-125F4	3.77	7.36	0.18	0.00	0.00	0.00	0.00	0.72	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	6.53	0.00	0.98	0.33	0.00	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.42	3.18	1.91	0.85	0.00	0.42	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1.15	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.45	11.23	13.13	1.33	2.47	1.71	0.19	0.19	3.81
myelodysplastic syndrome cell line:SKM-1	10772-110F7	77.24	39.73	4.62	4.25	2.40	0.92	0.55	0.18	1.29
myeloma cell line:PCM6	10474-106I6	1.98	2.17	0.00	0.00	0.00	0.00	0.00	1.98	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	15.22	4.06	4.06	3.04	2.54	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	82.18	15.30	1.18	4.90	0.20	0.39	2.35	0.98	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.82	8.02	0.22	0.89	0.22	0.11	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.72	6.99	0.74	0.96	0.15	0.22	0.07	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	78.93	21.53	3.31	6.07	1.10	0.00	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	5.29	7.36	0.00	0.00	0.00	0.46	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	221.70	109.44	73.90	8.61	16.84	15.72	4.68	0.94	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	10.76	9.49	3.16	1.05	0.42	0.21	0.00	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	3.17	5.03	0.00	0.00	0.19	0.19	0.00	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.00	21.35	6.41	0.95	3.80	0.71	0.00	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	5.86	7.60	3.01	0.63	1.27	0.48	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	3.42	6.04	1.21	0.81	1.21	0.40	0.20	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.91	3.81	3.18	0.64	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	80.91	19.16	27.68	6.92	3.19	3.73	1.33	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2.37	2.54	0.00	0.00	0.34	0.00	0.00	0.68	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	19.21	0.00	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.16	11.86	10.26	2.24	2.56	2.56	0.64	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	51.50	17.61	9.72	3.68	1.58	3.15	2.10	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	81.18	46.68	13.69	8.44	4.03	2.81	3.66	0.47	0.00
occipital cortex - adult, donor10196	10172-103C1	45.33	22.66	2.06	4.12	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	50.72	45.08	6.98	8.59	2.68	0.27	9.12	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	52.04	20.38	7.64	4.37	3.64	1.82	2.91	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	31.23	25.98	4.72	2.36	0.79	1.05	2.36	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	21.46	20.60	8.15	1.72	1.29	1.29	1.29	0.00	0.00
occipital pole, adult, pool1	10036-101E9	40.60	30.28	5.76	3.78	2.37	1.42	2.21	0.16	0.16
olfactory region, adult	10195-103E6	77.38	68.97	9.55	7.45	3.44	3.44	3.82	0.38	0.00
optic nerve, donor1	10277-104E7	24.01	6.00	2.00	4.00	0.00	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.14	6.15	0.11	0.91	0.68	0.00	0.00	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.08	11.82	0.41	0.27	0.27	0.00	0.27	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	63.67	14.90	5.76	5.93	1.35	2.03	1.19	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.28	6.93	0.35	1.04	0.35	0.23	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	57.03	11.46	4.70	4.12	1.47	1.18	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	34.57	7.47	7.47	2.80	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.69	13.15	6.15	1.91	2.33	0.64	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	120.98	28.56	11.88	11.01	3.14	2.71	7.60	2.01	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.11	8.25	1.65	2.75	0.37	0.18	0.55	0.37	0.00
pancreas, adult, donor1	10049-101G4	21.63	13.17	3.76	0.00	0.94	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	33.54	26.28	15.65	0.84	3.07	3.07	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	19.25	6.47	0.34	1.87	0.17	0.00	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.86	8.28	2.81	0.66	0.33	0.66	0.17	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	63.97	40.91	7.60	6.22	3.02	1.19	2.56	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	41.10	33.03	5.87	3.67	3.67	1.47	5.87	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	40.44	28.21	5.64	2.82	0.94	0.94	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	72.40	47.32	5.70	8.55	2.00	1.43	5.42	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	65.30	51.90	8.46	6.52	4.32	1.32	2.56	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	27.16	24.25	11.64	0.00	3.88	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	65.80	21.68	13.83	8.60	5.23	5.61	3.74	0.37	0.00
parotid gland, adult	10199-103F1	13.57	4.93	0.00	3.70	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	106.89	29.54	19.87	8.59	3.22	1.61	3.22	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	0.19	0.37	0.00	0.00	0.37	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.50	9.03	4.66	0.87	0.87	1.60	1.02	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	20.64	14.19	2.58	0.65	0.65	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	25.47	31.39	1.18	1.18	0.00	0.59	1.18	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	20.07	13.80	3.14	1.88	0.63	0.00	3.14	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	20.24	14.17	3.04	1.01	1.01	1.01	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	35.44	31.79	3.13	1.56	2.08	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	22.13	18.73	2.55	0.85	0.00	0.00	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	82.99	25.80	8.82	6.34	2.47	1.29	1.08	1.08	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	6.09	5.96	0.13	0.79	0.13	0.26	0.26	1.46	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.20	13.85	4.51	2.96	1.09	0.47	2.02	0.00	0.00
pons, adult, pool1	10033-101E6	30.12	25.65	4.82	2.32	1.38	1.81	2.67	0.09	0.17
postcentral gyrus, adult, pool1	10032-101E5	54.48	39.58	7.24	4.88	3.57	1.22	2.70	0.52	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	6.27	4.18	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	11.02	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.64	15.88	4.08	2.18	2.04	1.75	0.44	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	11.80	13.61	3.45	0.91	0.91	0.54	0.18	0.36	0.00
prostate, adult, pool1	10022-101D4	100.85	24.67	10.43	7.80	3.54	3.36	6.35	0.54	0.45
putamen, adult, donor10196	10176-103C5	68.46	56.89	7.08	7.79	2.83	1.89	6.61	0.47	0.47
putamen, adult, donor10252	10152-102I8	17.65	7.84	1.96	1.96	1.96	0.00	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	21.86	7.65	4.37	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.29	6.28	2.17	1.21	1.45	0.24	2.90	0.24	0.00
putamen, newborn, donor10223	10365-105F5	50.23	17.24	10.50	5.25	3.75	1.50	3.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	20.07	20.66	2.04	0.29	1.16	1.45	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	94.59	55.64	37.56	13.91	5.56	4.17	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.03	16.11	4.45	5.30	2.33	1.48	0.64	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	11.60	14.50	0.83	0.00	0.41	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	83.69	32.21	8.65	5.77	3.58	2.58	1.39	0.20	0.30
retinoblastoma cell line:Y79	10475-106I7	8.31	9.09	1.30	0.26	1.04	0.26	0.26	1.30	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.09	16.31	5.91	0.28	3.94	1.12	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	71.24	24.25	29.56	6.82	3.03	3.79	3.79	0.76	0.00
salivary acinar cells, donor1	11771-123I7	57.78	13.60	17.97	5.83	2.91	2.10	3.08	0.65	0.00
salivary acinar cells, donor2	11772-123I8	56.04	14.59	7.30	4.96	2.75	1.93	1.93	0.55	0.00
salivary acinar cells, donor3	11773-123I9	76.80	17.21	9.93	9.93	2.65	3.97	7.94	0.00	0.00
salivary gland, adult, pool1	10093-102C3	16.01	10.30	1.72	0.00	0.57	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.04	10.54	1.85	2.87	0.76	0.76	0.34	0.42	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.63	9.87	2.94	2.23	0.82	0.35	1.06	0.47	0.00
seminal vesicle, adult	10201-103F3	92.59	20.10	13.23	5.29	2.12	1.59	2.65	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.50	17.49	6.80	3.89	1.70	1.46	0.24	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.83	3.02	1.51	0.75	0.50	0.75	0.25	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	29.10	4.01	2.01	0.00	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.00	17.60	0.81	1.61	0.27	0.13	0.13	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	0.44	0.55	0.00	0.00	0.00	0.00	0.00	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.68	4.13	0.52	0.00	0.52	0.13	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	4.97	2.13	0.00	0.71	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	20.39	5.64	2.52	2.04	0.84	0.48	0.60	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	32.16	11.06	16.08	1.01	4.02	3.02	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	81.42	27.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	68.80	39.14	21.46	2.52	6.31	6.31	2.52	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	3.00	5.00	0.00	0.67	0.00	0.67	0.00	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	5.36	5.36	0.95	0.00	0.32	0.32	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	1.93	10.02	0.19	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	0.99	4.78	0.16	0.16	0.49	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2.25	13.67	0.32	0.00	0.32	0.16	0.00	0.80	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	2.62	8.06	0.00	0.00	0.44	0.22	0.00	46.63	0.00
small intestine, adult, pool1	10024-101D6	71.79	18.99	12.18	4.78	2.27	1.55	4.30	1.31	0.72
small intestine, fetal, donor1	10064-101I1	39.31	17.69	8.60	1.72	1.97	2.21	1.72	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	238.81	57.38	26.36	26.62	6.46	2.33	24.29	1.81	0.00
somatostatinoma cell line:QGP-1	10781-110G7	0.54	2.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	34.64	18.35	11.01	4.13	0.46	2.29	5.96	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	31.15	18.92	14.59	1.58	2.37	1.97	9.07	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	42.20	22.14	15.22	1.38	4.15	2.08	8.30	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	50.01	31.71	23.78	1.83	3.66	2.44	4.27	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	39.95	13.32	9.18	4.59	2.76	2.76	8.27	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	70.79	17.03	11.65	7.77	1.19	2.84	1.64	0.30	0.00
spleen, adult, pool1	10025-101D7	25.88	9.25	2.20	1.87	0.77	0.55	0.33	0.44	1.43
spleen, fetal, pool1	10044-101F8	43.86	19.55	4.37	2.15	1.83	1.19	0.72	0.32	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.04	4.55	0.00	0.21	0.00	0.10	0.00	7.76	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.34	10.63	0.00	0.19	0.38	0.00	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.15	20.62	6.64	2.45	2.10	1.05	1.40	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.25	3.13	0.00	0.00	0.00	0.00	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.75	3.49	0.34	0.45	0.11	0.11	0.11	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1.27	2.97	0.00	0.00	0.00	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.81	8.46	5.50	1.27	1.69	2.54	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	30.97	21.36	18.16	1.07	1.07	0.00	8.54	0.00	0.00
submaxillary gland, adult	10202-103F4	25.64	6.27	2.28	2.28	0.00	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	33.23	23.89	4.78	2.49	1.87	0.42	5.82	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	55.86	38.79	10.86	3.10	2.07	1.55	8.28	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	48.05	7.07	7.77	6.36	3.53	0.71	6.36	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.11	13.76	7.34	0.46	5.73	1.15	0.00	0.69	0.00
temporal lobe, adult, pool1	10031-101E4	85.70	57.47	10.09	8.65	3.81	2.29	3.48	0.34	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.07	24.93	15.67	2.14	2.85	0.71	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.45	23.30	8.35	1.76	1.32	1.32	1.32	0.44	0.00
tenocyte, donor1	11763-123H8	65.98	15.01	17.11	8.03	0.70	3.49	3.84	0.70	0.00
tenocyte, donor2	11765-123I1	64.09	15.64	19.84	8.01	2.67	3.05	7.25	0.00	0.00
tenocyte, donor3	11768-123I4	70.06	14.83	28.54	7.41	3.34	2.59	5.56	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.69	17.85	12.41	0.51	1.70	2.55	0.17	1.02	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	26.98	39.15	17.73	1.54	3.70	2.31	0.46	1.54	0.31
teratocarcinoma cell line:PA-1	10807-111A6	4.03	10.69	3.87	0.15	1.24	0.00	0.00	0.93	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.11	18.15	7.74	0.51	1.14	2.54	0.00	3.30	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	36.68	51.43	13.61	1.13	6.81	5.29	0.00	9.83	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	53.00	43.30	29.66	1.96	5.23	6.22	0.22	1.64	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	6.19	16.29	2.61	0.33	0.65	0.65	0.00	1.95	0.00
testis, adult, pool1	10026-101D8	82.14	30.82	12.03	8.27	2.15	2.25	2.47	19.86	0.00
testis, adult, pool2	10096-102C6	83.00	28.42	4.51	3.16	1.80	0.90	1.35	41.05	0.00
thalamus - adult, donor10196	10168-103B6	43.06	32.02	12.14	2.21	3.31	5.52	7.73	0.00	0.00
thalamus, adult, donor10252	10154-103A1	44.38	32.35	5.78	1.88	1.88	1.88	8.44	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	83.14	21.55	10.78	0.00	0.00	7.70	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.36	15.97	5.27	2.31	0.82	1.15	7.58	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	16.68	3.45	6.33	4.60	1.73	0.58	5.75	0.58	0.00
throat, adult	10209-103G2	40.20	16.48	5.74	2.75	2.50	1.25	3.25	0.50	0.25
throat, fetal, donor1	10061-101H7	34.74	24.07	11.27	2.74	2.13	3.66	0.61	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	2.19	5.56	0.79	0.00	0.99	0.20	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	34.30	18.89	10.34	3.68	4.18	2.29	2.98	1.19	11.23
thymus, fetal, pool1	10043-101F7	40.73	19.33	12.36	2.39	5.09	1.77	3.32	0.62	9.46
thyroid carcinoma cell line:KHM-5M	10776-110G2	47.87	11.04	2.26	3.59	1.06	0.53	0.80	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	22.77	7.26	2.10	2.37	0.56	0.56	0.28	0.42	0.00
thyroid, adult, pool1	10028-101E1	36.02	17.45	2.80	2.99	1.31	0.84	1.03	0.37	0.19
thyroid, fetal, donor1	10060-101H6	50.62	23.47	10.28	3.43	1.58	2.11	0.53	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	9.24	3.08	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	44.65	12.09	5.58	4.42	0.93	0.70	0.70	0.93	0.23
tongue, fetal, donor1	10059-101H5	39.02	21.68	9.46	1.18	2.36	1.58	0.39	0.00	0.79
tonsil, adult, pool1	10047-101G2	47.28	18.23	3.11	3.31	1.90	0.90	1.30	0.20	2.50
trachea, adult, pool1	10029-101E2	38.20	12.52	2.86	4.25	0.98	1.15	1.64	0.33	0.08
trachea, fetal, donor1	10058-101H4	26.93	17.70	15.77	3.46	4.23	3.46	2.31	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	77.94	16.65	21.61	7.44	3.19	1.77	4.96	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	15.30	5.07	1.01	1.52	0.41	0.41	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.16	10.18	18.65	1.88	3.29	3.76	1.10	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	45.66	5.71	19.03	5.71	7.61	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.39	3.30	0.42	0.25	0.17	0.42	0.00	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	60.51	41.73	12.52	2.09	2.09	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	445.51	79.85	87.19	20.82	7.34	14.50	15.70	1.02	0.34
uterus, fetal, donor1	10055-101H1	101.87	51.19	51.19	9.21	5.12	6.66	3.07	1.54	0.00
vagina, adult	10204-103F6	67.85	22.62	0.65	4.52	0.00	1.94	4.52	0.00	0.00
vein, adult	10191-103E2	53.92	14.47	7.67	5.04	2.85	1.53	1.75	0.22	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00